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ABSTRACT 
Relatively little is known about metastasis, the spread of cancer from the site of 
its origin to different organs in the body. Aberrant glycosylation of cell surface 
glycoproteins in cancer cells has been implicated in promoting cancer 
metastasis and consequent poor survival of cancer patients. In particular, 
aberrant glycans terminating in α-N-acetylgalctosamine (GalNAc), specifically 
recognized by the lectin Helix pomatia agglutinin (derived from the albumin 
gland of the Roman snail, Helix pomatia), have been described as a hallmark of 
aggressive cancers of the breast and several other sites. The research described 
in this thesis aims to study the role of HPA binding glycans in one of the most 
important, but poorly understood  steps of the metastatic cascade  namely 
cancer cell-endothelial cell adhesion and transendothelial migration, using a 
rocking adhesion assay system in a model of breast cancer metastasis. 
Three breast cancer epithelial cell lines - MCF 7 and ZR 75 1, derived from 
breast cancer metastases cells, and BT 747, derived from primary breast cancer 
were studied during adhesion to, and migration across, monolayers of human 
umbilical vein endothelial cells (HUVECs) . 
Initially, a confocal microscope compatible rocking adhesion assay system was 
developed and optimized in house. The rocking adhesion assay system was then 
used to study the role of HPA binding glycans in the adhesion of cancer cells to 
the endothelial cells. Results from the rocking adhesion assays showed a 
significant inhibition in the adhesion of MCF 7 and ZR 75 1 cells thereby 
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providing evidence that HPA binding glycans may play a functional role in the 
adhesion of breast cancer cell to endothelial cells. 
Behavior of the cancer cells post adhesion was studied using 24 hour time 
series experiments with a smartslide system and confocal microscopy. Further 
high resolution imaging was also carried out using scanning electron 
microscopy. The results have provided evidence that the behavior of cancer 
cells during adhesion and transendothelial migration during metastasis is 
similar to that described for leucocytes during the inflammatory response. Like 
leucocytes, after adhesion, cancer cells were imaged moving along the 
endothelial cell layer. The imaging further showed the retraction of endothelial 
cells and the cancer cells settling and dividing in the gap produced by 
endothelial retraction. In addition to this, transcellular migration was also 
imaged using scanning electron microscopy. 
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1.1 Breast Cancer- UK statistics 
Breast cancer is the commonest cancer in the UK. The incidence rates of breast 
cancer have risen by 50% in the last 25 years. Breast cancer is now the second 
commonest cause of cancer deaths in the UK, killing approximately 12,000 
women and 70 men each year (http://info.cancerresearchuk.org/cancerstats, 
2010). The most common cause of cancer related deaths in patients with breast 
cancers and other cancers is metastasis, the spread of the cancer from the 
primary site to various organs in the body. For example, most patients with 
metastatic breast cancer at the time of initial diagnosis do not survive beyond 
24 months (Gennari et al., 2005, Kiely et al., 2011). In comparison to this, 70-
95% of patients presenting with cancers confined to the breast with no axillary 
or distant metastasis survive for 5 years and beyond (Rosen et al., 1993, 
Hanrahan et al., 2007). 
1.2. Cancer Metastasis 
Metastasis is the spread of cancer from its primary site of origin to 
discontiguous nearby or distant sites where secondary, extracellular foci of 
tumours are formed (reviewed byWelch, 2006). Metastasis occurs most 
commonly via blood (haematogenous metastasis) or via lymphatics. In addition 
to these common routes of metastasis, some cancers also utilise, other, less 
common methods for their spread. For example, ovarian cancers metastasise by 
direct spread across the peritoneal cavity (Carmignani et al., 2003). Prostatic 
cancers and cancers of the head and neck spread by perineural invasion (Carter 
and Pittam, 1980, Villers et al., 1989). Malignant melanomas spread by 
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migrating outside the lumen of blood vessels into the space between endothelial 
cells and the basement membrane by a process called as extra luminal 
migratory metastasis (Lugassy et al., 2004). Common routes of cancer 
metastasis are illustrated in Figure 1.1.  
 
 
Figure 1.1: Routes of metastatic spread in the body: Lymphatic metastasis, 
haematogenous metastasis and direct spread across body cavities. 
 
Metastasis is a complex, multi-step process. To successfully metastasize, cancer 
cells have to complete a series of interlinked steps in succession. Hence, the 
process of metastasis is often described as a cascade. The research project 
described in this thesis focuses on a specific step of the metastatic cascade 
utilised by breast cancers for haematogenous metastasis. Hence, a brief review 
of metastatic cascade with particular reference to haematogenous metastasis is 
given below. Steps 1-3 also occur in other modes of metastasis. 
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Metastatic cascade consists of the following key steps (Tarin and Matsumura, 
1994): 
1. Angiogenesis or formation of new blood vessels by the growing tumour. 
2. Detachment of the tumour cells from the main tumour mass. 
3. Migration of cancer cells through the basement membrane and 
extracellular matrix surrounding the tumour mass and intravasation in to 
the local blood vessels  
4. Dissemination of the tumour cells to distant organs through blood. 
5. Adhesion of the tumour cells to the endothelial cells and basement 
membrane of the blood vessels and subsequent extravasation in to the 
organs. 
6. Seeding of the tumour cells in the organs and growth of metastatic 
tumour foci.  
The steps of the metastatic cascade are shown in figure 1.2 below and described 
in detail in sections 1.2.1- 1.2.6 
1.2.1. Angiogenesis 
Unregulated and autonomous growth is one of the hallmarks of cancers. 
However, despite possessing this potential for unrestrained growth, tumours 
cannot grow beyond 1-2mm in diameter by relying exclusively on the existing 
blood supply of the organ from which they originate (Gimbrone et al., 1972). 
For their sustenance and continued growth, it is essential for tumours to  
Chapter 1: Introduction   
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Figure 1.2.Steps of the metastatic cascade: Metastasis is a multistep process 
consisting of angiogenesis, detachment of tumour cells, intravasation, 
dissemination, adhesion and transendothelial migration and growth of 
metastatic tumour foci. 
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establish a new network of blood vessels and this neovascularisation is 
achieved primarily by angiogenesis. Angiogenesis is a process in which new 
blood vessels are generated by utilising the dormant endothelial cells lining the 
existing vasculature of the organ. 
Angiogenesis in tumours, as in normal tissues, is triggered by hypoxia in the 
tissue micro environment. Hypoxia triggers angiogenesis by stabilizing and 
activating the transcription factor, hypoxia inducing factor -1(HIF-1). HIF-1 in 
turn induces the action of the growth factor, vascular endothelial growth factor 
(VEGF), a potent stimulant of angiogenesis (Leung et al., 1989, Dery et al., 
2005). In addition to VEGF, angiogenesis in tumours is also mediated by 
various cytokines and growth factors including epidermal growth factor (EGF), 
fibroblast derived growth factor (FGF) and transforming growth factor β (TGF- 
β), which stimulate angiogenesis directly, and other stimulants like tumour 
necrosis factor alpha (TNFα), interleukin (IL-1β), insulin derived growth factor 
(IGF) and epidermal growth factor (EGF), which stimulate angiogenesis 
indirectly by their action on HIF-1. The action of these stimulants on the 
dormant endothelial cells leads to an increase in vascular permeability and 
detachment of the endothelial cells. The detached endothelial cells then 
proliferate into the tumour stroma to sprout new capillaries and accomplish 
neovascularisation of the tumour mass (Hanahan and Folkman, 1996, Cook and 
Figg, 2010) 
Angiogenesis in normal adults is a highly restricted process and occurs only in 
conditions like wound healing and during menstrual cycle where regeneration 
Chapter 1: Introduction   
  14 
of damaged blood vessels is essential. Under these physiological conditions, 
angiogenesis is regulated by a delicate, well regulated balance between pro and 
anti angiogenic factors. This balance is however, lost in tumour angiogenesis 
and results in the formation of poorly structured, leaky blood vessels which are 
not properly fortified by pericytes and basement membrane (Bockhorn et al., 
2007). This defective structure of the blood vessels is utilised by cancer cells 
for intravasation and provides them access to blood stream and thereby entry in 
to systemic circulation. 
1.2.2. Detachment of the cancer cells from the main tumour 
Tumour cells possess reduced cell-to-cell adhesion compared to normal cells 
and this has been attributed to the loss or down regulation of the adhesion 
molecule E-cadherin which is a trans membrane glycoprotein (Brooks et al., 
2010).  E-cadherin regulates cell to cell adhesion, interaction and polarity in 
normal cells and inactivation of E-cadherin is a predominant feature of cancers 
(Jeanes et al., 2008, Brooks et al., 2009, Berx and Roy, 2009) and results in 
reduced cell-to-cell adhesion. This facilitates the detachment of the cancer cells 
from the main tumour mass.  
1.2.3. Migration of cancer cells through the basement membrane and 
extracellular matrix surrounding the tumour mass and intravasation in to 
blood vessels 
During invasion of the basement membrane by the cancer cells, several changes 
are brought about in the cancer cells and the surrounding stromal cells. The 
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cancer cells extend pseudopodia and several hydrolytic enzymes including 
matrix metalloproteinases (MMP’s), urokinases and cathepsins are activated 
and released by these cancer cells. The basement membrane and extracellular 
matrix is digested by the action of these enzymes. The tumour cells then adhere 
to the degraded extracellular matrix and detach from the main tumour mass  
(François-Clément Bidard and Poupon., 2008, Brooks et al., 2009). 
Several changes are also brought about in the basement membrane of the 
tumour and in the extracellular matrix. The basement membrane and the 
extracellular matrix are thinned out by the compression forces of the growing 
tumour, facilitating invasion by cancer cells.  Compared to normal tissues, the 
extracellular matrix and stroma of tumours are stiffer. This increased stiffness is 
utilised by cancer cells to produce increased tractional forces resulting in 
remodelling of the extracellular matrix and linear rearrangement of collagen 
fibres. The tumour cells then form motility tracks in the extracellular matrix and 
migrate through these tracks to reach the basement membrane of blood vessels 
and lymphatics (Kumar and Weaver, 2009). 
Invasion through basement membrane and into the blood vessels of the tumour 
is brought about by both active and passive mechanisms. The process is 
facilitated by the leaky and fenestrated structure of the newly formed blood 
vessels as described in section 1.2.1.  
In the active mechanism, cancer cells manipulate the cytoskeleton to produce 
targeted migration towards the basement membrane. Then, they adhere to and 
pass through the basement membrane and endothelial cells to gain entry in to 
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the blood vessels. In the passive mechanism, the cancer cells gain entry in to 
blood vessels and lymphatics when these vessels collapse as a result of the 
mechanical stress produced by unregulated tumour growth in a confined space 
(Bockhorn et al., 2007). 
1.2.4. Dissemination to distant organs 
Once cancer cells have gained entry in to the blood stream, they are subjected 
to shear forces from the flow of the blood and attack from the immune system. 
Though millions of tumour cells are shed in to the blood stream, it has been 
reported that less than 0.1% of the circulating cells are actually able to survive 
these attacks and successfully metastasize (Weiss, 2000). The surviving cancer 
cells reach various organs and arrest in the microvasculature of these organs.  
1.2.5. Adhesion of the cancer cells to endothelial cells and transendothelial 
migration 
Once the cancer cells have reached the microvasculature of the organs that they 
metastasise to, they interact with the endothelial cells lining the blood vessels 
and migrate out of the blood vessels. This step, the interaction between the 
cancer cells and endothelial cells and the subsequent migration of cancer cells 
out of the blood vessels, is the focus of the research project described in this 
thesis. This step is explained in more detail in section 1.3. 
Each type of cancer displays a distinctive pattern of dissemination. For 
example, breast cancers tend to metastasise to liver, bones, lungs and brain. The 
exact mechanisms underlying this organ-specific pattern of metastasis is 
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incompletely understood and two long-standing schools of thought still exist on 
this matter. 
The first school of thought favours the ‘seed and soil hypothesis’, first proposed 
by Stephen Paget in 1889, in which tumour cells are compared to seeds, and the 
target organs to soil (as cited in Fokas et al., 2007). Tumour cells selectively 
metastasise to organs that have the right conditions for their growth. 
The alternative, mechanical entrapment theory was first proposed by James 
Ewing in 1928 [as cited by (Chambers et al., 2002)] who suggested that tumour 
cells become mechanically entrapped in the capillary bed of the first organ they 
encounter and therefore preferentially metastasize to that organ. 
It is now believed that mechanical entrapment alone, while it does occur, is not 
sufficient to explain the organ specific pattern of tumour metastasis (Glinskii et 
al., 2005) and that there are specific and selective molecular interactions 
between tumour cells and the cells of the organs to which they metastasise 
(Hart and Fidler, 1980, Fokas et al., 2007); however, this is an area that is not 
well researched and is incompletely understood. 
1.2.6. Seeding of the tumour cells and growth of new tumour foci 
To be able to successfully metastasize, cancer cells have to manipulate the 
environment of the tissues that they metastasise to. For example, during bony 
metastasis, tumour cells destroy the balance between the activity of osteoblasts 
(cells that deposit bone) and osteoclasts (cells that remove bone) resulting in 
bone resorption. By thus manipulating the host environment, tumour cells 
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create conditions that are favourable for their growth and proliferation (Welch, 
2006).  
Once they have seeded in the target organs, the same factors that supported the 
growth of the primary tumours namely, limitless replicative potential, ability to 
mimic growth signals, insensitivity to anti-growth signals, resistance to 
apoptosis and sustained angiogenesis also help the metastatic tumours to 
flourish in the target organs (Hanahan and Weinberg, 2000). 
1.3. Adhesion and transendothelial migration 
As described in the section 1.2.5, the tumour cells which have reached the 
microvasculature of the target organs have to adhere to, and interact with, the 
endothelial cells and the basement membrane of these vessels prior to 
extravasation and growth in the target organs.  
During these interactions, tumour cells are believed to employ some of the 
molecular mechanisms that are utilized by leucocytes for adhesion and 
transendothelial migration during the normal process of inflammation. This 
process has been described as ‘leucocyte mimicry’ (Barthel et al., 2007, Albini, 
1998). Though both cancer cells and leucocytes appear to, at least in part, 
utilize the same mechanisms for adhesion and transendothelial migration, the 
process has been extensively studied in leucocytes and relatively little studied 
in cancer cells. Hence, adhesion and transendothelial migration of leucocytes as 
a paradigm for metastasis is described below. 
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1.3.1. Leucocyte adhesion and transendothelial migration – a paradigm for 
metastasis 
Four key steps are involved in the adhesion and transendothelial migration of 
leucocytes. They are described by Barreiro and Sanchez-Madrid (2009) and are 
as follows: 
1. Tethering and rolling of leucocytes by selectin-carbohydrate mediated 
interactions. 
2. Activation of integrins. 
3. Integrin mediated firm adhesions between leucocytes and endothelial cells 
and crawling of the leucocytes on the endothelial cell layer. 
4. Transmigration of the leucocytes out of the blood vessel mediated by 
members of the immunoglobulin superfamily. 
Selectins, integrins and members of the immunoglobulin superfamily (IgSF) 
play a vital role in the extravasation of leucocytes, and possibly of cancer cells. 
Hence a brief review of their structure, relevant types and function is given 
below. 
1.3.1.1 Selectins  
Selectins are a family of type-1, transmembrane glycoproteins consisting of 
three members, P-selectin, E-selectin and L-selectin. P-selectin is expressed by 
platelets and endothelial cells, E-selectin by endothelial cells and L-selectin by 
leucocytes. The three members of the selectin family share a similar structure 
consisting of an extracellular domain, a transmembrane sequence and a 
Chapter 1: Introduction   
  20 
cytoplasmic domain. A schematic representation of selectin structure is shown 
in the Figure 1.3.  
The extracellular domain has a N-terminal carbohydrate recognition, lectin-type 
domain (which is similar to that of C-type or Ca
2+
-dependant type lectin), an 
epidermal growth factor like or EGF- like domain and a multiple short 
consensus repeat or SCR domain. The SCR domain is followed by the trans 
membrane sequence and a short cytoplasmic, C-terminal domain (Bevilacqua 
and Nelson, 1993, Symon and Wardlaw, 1996). 
L-selectin is present on the projections of microvilli on unstimulated 
neutrophils. Unlike L-selectin, P- and E-selectins are up-regulated during 
inflammation by the cytokines, thrombin or histamine (Tedder et al., 1995). 
The binding partners for selectins include fucosylated and sialylated 
carbohydrates including ligands with heavily O-glycosylated, mucin like 
domains, sialyl Lewis
a
 and sialyl Lewis
x
 antigens (Varki and Varki, 2001, 
Symon and Wardlaw, 1996).  
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Figure 1.3.Schematic representation of the structure of selectins: Selectins are 
made up of an extra cellular domain, a transmembrane sequence and a 
cytoplasmic domain. Adapted from (Bevilacqua and Nelson, 1993). 
1.3.1.2. Integrins 
Integrins are a family of more than 20 cell surface receptors that are vital in 
cell-cell and cell-extracellular matrix interactions (Barreiro and Sanchez-
Madrid, 2009). Structurally, integrins are heterodimeric, composed of two 
noncovalently linked sub units- α chains and β chains. The two chains contain 
an extracellular domain, a transmembrane sequence and a cytoplasmic domain 
(Brooks et al., 2009)  
α chain has a head region made up of a β propeller domain and a thigh domain. 
The thigh domain, in turn, is linked to two calf-domains, calf -1 and calf- 2. In 
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some integrins, a domain with 200 amino acids called the α1 domain is inserted 
into the β propeller domain.  
The extracellular domain of the β chains contains a hybrid domain, a plexin-
semaphorin integrin (PSI) domain, a β1 domain and four epidermal growth 
factor (EGF) repeats (Barczyk M, 2010). A schematic representation of integrin 
structure is shown in the figure 1.4.  
Integrins perform their functions by dynamically changing their conformation. 
The α chain is responsible for ligand binding. The β chain is closely linked with 
the cytoskeleton through its cytoplasmic tail and helps mediate the interactions 
with the cytoskeleton.  
In their resting or inactive state, integrins are present in a compact, bent form. 
The action of integrins is initiated when talin, a protein present in the 
cytoskeleton, binds to the cytoplasmic tail of the β chain. This binding sends a 
signal to the α chain of the integrin, causing it to extend to a small degree. This 
partly extended state is called the primed position and helps to expose the 
ligand binding site on the α chain. The ligand then binds to the α chain and 
extends the α chain further, making it achieve its active form. The tractional 
force produced by this extension is transmitted to the cytoplasmic tail of the β 
chain and through it to the cytoskeleton. This switches on various intra cellular 
signalling cascades mediating cell to cell interactions and various other 
functions (Askari et al., 2009 ).  
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Figure 1.4: Schematic representation of the structure of integrins. The α and β 
chains have an extra cellular domain, a transmembrane sequence and a 
cytoplasmic domain. The components of the individual chains are explained in 
the section 1.3.12. Adapted from (Barczyk et al., 2010). 
1.3.1.3. Immunoglobulin super family (IgSF) adhesion molecules 
 Binding partners of integrins are the members of the immunoglobulin 
superfamily. These include intercellular adhesion molecules (ICAMs) 1-5, 
vascular adhesion molecule- 1 (VCAM-1), junctional adhesion molecules 
(JAMs) A, B and C and platelet-endothelial adhesion molecules (PECAMs).  
 Functionally, as the binding partners of integrins, these adhesion molecules 
play a central role in the adhesion and transendothelial migration of leucocytes 
during inflammation. ICAM-1 and VCAM-1 are involved in integrin mediated 
leucocyte adhesion. ICAM-1, and VCAM -1 along with ICAM-2, JAM-B, 
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JAM-C and PECAM are involved in transendothelial migration (Barreiro and 
Sanchez-Madrid, 2009). 
1.4. The leucocyte adhesion cascade 
1.4.1. Tethering and rolling of leucocytes by selectin-carbohydrate mediated 
interactions 
Tethering and rolling of leucocytes, the first step in the events leading to 
leucocyte extravasation is largely mediated by selectins and their ligands.  
Leucocyte rolling on endothelial cells begins minutes after tissue injury. In 
response to injury, several mediators of inflammation – for example, histamine, 
thrombin and cytokines - are generated at the site of injury. These mediators 
activate P-selectin from intracellular stores which mediates the early phase of 
rolling (Tedder et al., 1995).  
There are two phases to rolling, both requiring a close interaction of selectins 
and their ligands. Initially, the leucocytes form transient association-
dissociation interactions with the blood vessel wall. This process is called 
tethering and is mediated by P- selectin and its ligand, P-selectin glycoprotein 
ligand 1 (PSGL1). Tethering captures the circulating leucocytes and slows them 
down.  
Tethering is converted to more stable rolling by the interaction between E- 
selectin and its ligand E-selectin ligand1 (ESL1). Slow rolling correctly 
orientates the L- selectin on the leucocytes and promotes their binding to 
PSGL1 (Barreiro and Sanchez-Madrid, 2009). These processes help the next 
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step in the leucocyte adhesion cascade, namely activation of integrins on the 
surface of the leucocytes. 
1.4.2. Activation of integrins 
As explained in the previous section, selectin mediated interactions recruit 
leucocytes and cause them to roll along the endothelial cells. This allows them 
to come in to contact with various chemokines, for example, TNFα and 
interleukin-8 (IL-8) expressed on the surface of the endothelial cells. These, in 
turn, activate integrins on the surface of the leucocytes. In addition to activation 
by chemokines, integrins are also activated by intracellular signalling produced 
by the binding of L-selectins (Crockett-Torabi, 1998). As explained in the 
section 1.3.12, these signals bring about conformational changes in the integrins 
and initiate the next step in the adhesion cascade, namely integrin mediated 
firm adhesion. 
1.4.3. Integrin mediated firm adhesion 
Integrin mediated leucocyte adhesion takes place in two stages. In the first 
stage, the leucocytes crawl along the endothelial surface. This is essential for 
the leucocytes to reach the site appropriate for transendothelial migration.  
Once the leukocytes have reached the appropriate place on the endothelial cell 
layer, the integrins react with the activated adhesion molecules ICAM-1 and 
VCAM-1 (described in the section 1.3.13) and adhere firmly to the endothelial 
cell layer (Gahmberg et al., 1997, Penberthy et al., 1997). This adhesion is 
believed to be reinforced by  ICAM-1 and VCAM-1 by the production of 
‘leukocyte docking structures’ which prevent the adherent leukocytes from 
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detaching under the shear forces produced by blood flow and aid their 
transmigration through the endothelial cell layer (Barreiro and Sanchez-Madrid, 
2009).  
1.4.4. Transmigration of leucocytes 
Following integrin mediated adhesion, the next stage is the transmigration of 
the leucocyte across the endothelial layer. During this process, microvilli on the 
endothelial cells actively surround the adherent leucocytes in a cup like 
structure called the transmigratory cup. The formation of transmigratory cup is 
mediated by ICAMs.  
Leucocytes then employ two routes of transmigration. In the first route, 
leucocytes use diapedesis to squeeze out between adjacent endothelial cells 
aided by the action of JAMs and PECAMs (described in section 1.3.13). This 
mechanism is called Para cellular migration. In the second route, leucocytes 
pass through the endothelial cells themselves to migrate out. This is called 
transcellular migration (Rahman and Fazal, 2009). Both mechanisms are 
believed to play an equally important role in transendothelial migration of 
leucocytes. Adhesion and transendothelial migration of leucocytes is illustrated 
in the Figure 1.5 
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Figure.1.5. Leucocyte adhesion cascade. Leucocytes captured from blood 
stream roll along endothelial cells by selectin-mediated interactions. Rolling 
activates integrins and they cause firm adhesion of the leucocytes to the 
endothelial cells. The adherent leucocytes extravasate in to the site of their 
action. Adapted from (Vestweber and Blanks, 1999). 
 
1.5. Adhesion and transendothelial migration of tumour cells 
As explained in the section 1.3, metastasising cancer cells are believed to 
employ mechanisms similar to those used by leucocytes during inflammation 
(Strell and Entschladen, 2008). Selectins appear to be the main mediators of 
rolling in cancer cells and expression of selectin ligands has been shown to 
result in enhanced metastatic capability (Kannagi et al., 2004, Strell and 
Entschladen, 2008).  Expression of E- selectin ligands which mediate E-selectin 
mediated binding to endothelial cells has been shown in metastatic prostate 
carcinoma cells (Dimitroff et al., 2005). In addition to this, cancer cells are 
believed to induce endothelial E-selectin expression (Kannagi et al., 2004) and 
facilitate selectin mediated rolling.  In colon cancer cells E, P and L-selectins 
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have been shown to mediate slow, intermediate and fast rolling respectively 
(Hanley et al., 2006).  Similar to the events during leucocyte adhesion and 
transendothelial migration, P-selectin binding has been shown to produce 
integrin activation in colon carcinoma cells (Reyes-Reyes et al., 2006).  In 
addition to this, N-cadherins have been shown to mediate the rolling of cells of 
the breast cancer cell line MDA-MB-468, thereby indicating that in some 
cancers mediators other than selectins might be involved in cancer cell rolling 
on endothelial cell surface (Strell et al., 2007).  In addition to their role in 
mediating cancer cell rolling on endothelial cell layer, selectins have also been 
shown to mediate diapedesis of cancer cells (Tremblay et al., 2008) . 
In leucocytes, integrins mediate firm adhesion of leucocytes to the endothelial 
monolayer and this process has been described in sections 1.4.2 and 1.4.3. 
Similarly, integrin mediated firm adhesion has also been shown to occur in 
cancer cells. In nude mice, very late antigen integrin 4 (VLA-4) mediated 
binding of melanoma cells to its ligand VCAM-1 was demonstrated, and 
resulted in an increase in the formation of metastatic colonies (Garofalo et al., 
1995). In addition to integrins, galectins have been implicated in mediating firm 
adhesion of breast and prostate cancer cells to the endothelium (Glinsky et al., 
2001).  
Following firm adhesion of cancer cells, endothelial retraction is brought about 
to facilitate cancer cell transmigration across the endothelial layer. The tumour 
cells then degrade the basement membrane by the action of several enzymes, 
predominantly collagenase IV, and migrate into the stroma of the target organ 
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(Albini, 1998).  The steps of tumour adhesion and extravasation are shown in 
the Figure 1.6.   
 
Figure.1.6.Adhesion and transendothelial migration of cancer cells: Cancer 
cells initially roll along the endothelial layer by predominantly selectin 
mediated interaction. This results in integrin mediated firm adhesion following 
which the cancer cell migrate out across the endothelial cell layer.  
1.6. Glycosylation in human cells 
It is clear from the description of metastatic cascade in the previous sections 
that metastasis is an extremely complex process which relies on the interplay of 
a diverse family of cell surface receptors and their ligands. Of particular 
importance to this project is the fact that several of these molecules are either 
glycoproteins or substances which interact with them. Abnormal glycosylation 
of cell surface glycoproteins is a salient feature of cancers. This project aims to 
investigate the role played by abnormal cell surface glycans present on cancer 
cells during adhesion and transendothelial migration step of the metastatic 
cascade, focussing on breast cancer as a model system. It is of paramount 
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importance, therefore, to have a clear understanding of the fundamental 
concepts of glycobiology, including basic carbohydrate chemistry. It is beyond 
the scope of this thesis to describe carbohydrate chemistry in detail. For an in 
depth, explanation of carbohydrate chemistry and glycosylation, please refer to 
a standard text book of glycobiology [for example (Brooks, 2002, Varki, 
1999)]. However, some fundamental concepts essential to understand the 
process of cell surface glycosylation and its abnormalities is outlined in the 
following sections.  
1.6.1. Structure of Glycoproteins 
Glycoproteins are proteins in which glycans, either in linear or branching 
chains, are linked covalently to the polypeptide backbone usually via N- or O-
linkages. Glycan is a generic term utilised in glycobiology to describe a 
carbohydrate in mono, oligo or poly saccharide form (Varki, 2009). N- and O-
linkages are described in detail in sections 1.6.2 - 1.6.4 
In humans, the carbohydrate moiety of glycoproteins is formed by a 
combination of seven monosaccharides, glucose (Glc), galactose (Gal), 
mannose (Man), fucose (Fuc), N-acetylgalactosamine (GalNAc), N-
acetylglucosamine (GlcNAc) and sialic acids (SA). The 7 monosaccharides, 
their Fischer and Haworth projection formulae and the symbols and 
abbreviations used to represent them in this thesis are given in the Table 1.1. 
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Table.1.1.The seven monosaccharides utilised in cell surface glycosylation in 
humans. Adapted from (Brooks et al., 2002). 
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1.6.2. Carbohydrate chemistry 
The complexities of carbohydrate chemistry are well reviewed by Varki et al 
1999 and Brooks et al, 2002. Carbohydrates are defined as polyhydroxy 
aldehydes or poly hydroxyketones or their derivatives, or substances which can 
be hydrolysed to produce these compounds. Monosaccharides are the simplest 
form of carbohydrates and are the building blocks of more complex 
carbohydrates. Monosaccharides occur in open chain or ring forms, the 
structurally stable ring forms being more prevalent. The structural backbone of 
a monosaccharide is formed by an unbranched chain of carbon atoms 
covalently linked to each other and in turn linked to groups including–CHO, -
H, -OH and -CH2OH.  
The carbon atoms of a monosaccharide are conventionally numbered 1,2,3 and 
so on with the carbon atom linked to the carbonyl or C=O group being 
numbered 1(Figure.1.7 a).  
Linear forms of carbohydrates are present in L- or D-configurations depending 
upon whether the -OH group linked to the highest numbered asymmetric carbon 
atom is to the left or right of the chain respectively. The ring forms are present 
in α and β anomeric forms depending on whether the -OH group linked to the 
anomeric carbon atom, C1, lies below the plane of the ring or above it. The 
linear and ring forms of monosaccharides in their various conformations are 
illustrated in figures 1.7a-d with glucose as an example. 
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Figures.1.7: Structure of D- and L-glucose: The carbon atom linked to the 
carbonyl group (shown in red) is numbered 1. The -OH group attached to the 
highest numbered asymmetric carbon atom (in green) is to the right in the D-
form (1.7.a) and to the left in the L-form (1.7.b). The OH group linked to the 
anomeric carbon atom (in green) is below the plane of the ring in the α form 
(Figure 1.7.c) and above the plane of the ring, in the β form (Figure1.7.d). 
Adapted from (Brooks et al., 2002) 
Oligosaccharides are made up of linear or branching chains consisting of a variable 
number of monosaccharides. The chains are formed by a reaction between the -OH groups 
of two monosaccharides with elimination of a molecule of water. The resulting bond 
containing acetal oxygen is called a glycosidic bond.  If the glycosidic bond is axial, i.e. 
below the plane of the ring of the left hand monosaccharide involved in the reaction, it is 
termed α-glycosidic linkage. If the bond is equatorial i.e. above the plane of the ring of the 
left hand monosaccharide involved in the reaction, it is termed a β-glycosidic linkage 
(Varki et al., 2009., Brooks et al., 2002). 
As described above, monosaccharides in a chain can be linked with α and β 
glycosidic bonds, the linkages can be formed between different carbon atoms of 
a monosaccharide chain (for example, to form a 13, 16, 23 linkage etc.) 
and glycan chains of variable length and complexity that are linear or branched 
can be formed. This can potentially give rise to a vast array of glycans. In 
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addition to this, glycan synthesis is not under direct genetic control. A protein 
may have several potential glycosylation sites but the choice of glycosylation 
site that is actually utilised for glycosylation is governed by several factors 
including the availability of appropriate carbohydrate substitutes, cellular 
environment, like pH, and availability and activity of the specific enzymes 
required for glycosylation. All these factors result in immense and extremely 
complex structural diversity of glycoproteins.  
1.6.3. Glycoproteins Synthesis 
Glycoproteins are synthesized in the endoplasmic reticulum (ER) and the Golgi 
apparatus (GA). The glycans may be N-linked or O-linked to the polypeptide.  
An insight in to the biosynthesis of N-linked and O-linked glycosylation is of 
paramount importance in understanding the abnormal glycosylation changes in 
cancer described in sections 1.7-1.8 of this thesis. Hence, a brief review of the 
biosynthesis of N and O-linked glycosylation is given below. 
1.6.4. Synthesis of N-linked glycans 
N-linked glycosylation is a co-translational event being initiated during the 
synthesis of the polypeptide chain. It is initiated in the endoplasmic reticulum 
(ER) with the GlcNAc molecule from an oligosaccharide forming a β-N 
glycosidic linkage with the amide group of the amino acid asparagine (Asn). It 
is a prerequisite in N-linked glycosylation that this asparagine is within a 
consensus amino acid sequence asparagine-X-serine/threonine (where X may 
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be any amino acid other than proline). The steps in the N-linked glycosylation 
are shown in the Figure 1.8. and are described below: 
1. The first step in N-linked glycosylation is the synthesis of dolichol 
linked oligosaccharide intermediate, Man5GlcNAc2-phosphate-dol 
(consisting of 5 mannose residues and two GlcNAc residues), in the 
cytoplasm by the action of corresponding glycosyltransferases. At the 
same time, the growing polypeptide chain, still under active 
construction on the ribosome, is fed into the rough endoplasmic 
reticulum (RER) lumen. 
2. The oligosaccharide intermediate is then flipped across the RER 
membrane into the lumen. 
3. In the RER, the oligosaccharide intermediate is further extended by 
addition of 3 glucose and 5 mannose residues to form 
Glc3Man9GlcNAc2-phosphate-dol.   
4. The oligosaccharide intermediate is then cleaved from the dolichol 
molecule and linked instead to the asparagine residue of the nascent 
polypeptide chain (with the previously described consensus amino acid 
sequence). This reaction is catalysed by the action of the enzyme 
complex, oligosaccharyltransferase (OST). 
5. Following the attachment to the polypeptide chain, the oligosaccharide 
intermediate is trimmed by glucosidase and mannosidase enzymes 
which remove 3 glucose residues and one mannose residue, 
respectively, resulting in the formation of Man8GlcNAc2-Asn. This 
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trimming is essential for the correct folding of the polypeptide chain and 
is a vital step in the biosynthesis of N-linked glycoproteins. 
6. The glycoprotein is then transferred to the GA where further mannose 
residues are cleaved giving rise to a range of structures, most commonly 
Man5GlcNAc2-Asn. Central to the structure of all N-linked 
glycoproteins is the presence of a trimannosyl core consisting of 
Man3GlcNAc2-Asn.  
7. These trimmed structures are then further extended to give three main 
types of N-linked glycoproteins. They are high mannose type, complex 
type and hybrid type. The high mannose type glycans have five to nine 
mannose residues attached to the trimannosyl core. The complex type 
glycans are characterized by the presence of lactosamine units 
GlcNAc(β1→4)GlcNAc. These lactosamine units make up the 
polylactosamine units (GlcNAc(β1→4)GlcNAc)n which in turn form 
the antennae of the branched N-linked chains. The hybrid glycans 
contain features of both the high mannosyl and complex type glycans. 
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Figure.1.8.Schematic representation of N-linked glycosylation: Dolichol linked 
Man5GlcNAc2-phosphate is formed in cytoplasm and flipped into the lumen. 
The oligosaccharide chain is extended to form Glc3Man9GlcNAc2-P-dol, 
cleaved from dolichol and attached to nascent polypeptide chain. The 
oligosaccharide is trimmed to Man8GlcNAc2. Monosaccharide symbols are 
given in Table.1.1. Adapted from (Brooks et al., 2002). 
1.6.5. Synthesis of O-linked glycans 
O-linked glycosylation is simpler than N-linked glycosylation.  It takes place in 
the Golgi apparatus. Unlike N-linked glycosylation, O-linked glycosylation is 
an entirely post transational event, i.e. it takes place after the synthesis and 
folding of the protein chain. 
Individual monosaccharides are added in a step wise manner to the protein 
chain and addition of each monosaccharide is catalysed by a specific 
glycosyltransferase. O-linked glycans usually contain the monosaccharides 
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GalNAc, GlcNAc, Gal, Fuc and sialic acids, although other monosaccharides 
can also be present. The steps in O-linked glycan synthesis are described below.  
1. O-linked glycosylation begins in the cis-compartment of the Golgi 
apparatus, most usually by the addition of a GalNAc to serine or 
threonine residue of the polypeptide chain to give rise to GalNAc-O-
Ser/Thr. This structure is termed Tn antigen. The structure of Tn antigen 
is shown in Figure1.9. The reaction is catalysed by a family of GalNAc 
polypeptide transferases (ppGalNAc-Ts). Unlike N-linked 
glycosylation, a consensus amino acid sequence is not required for O-
linked glycan attachment, although features characterising the sites of 
attachment have been described (Brooks et al., 2008b). 
 
Figure.1.9.Schematic representation of the structure of Tn antigen:  Tn 
antigen is the first glycan synthesized in O-linked glycosylation. For 
monosaccharide symbols, see Table 1.1. Adapted from (Brooks et al., 2002)  
2. Tn antigen is normally not exposed in healthy cells, although it is often 
left unelaborated and exposed in cancer cells (Lisowska, 1995). It is 
usually either terminated by sialylation or extended by the stepwise 
addition of more monosaccharides. For example, addition of Gal by a 
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(β1→3) linkage to the Tn antigen gives rise to Gal(β1→3) GalNAc-
Ser/Thr as shown in Figure 1.10. This structure is called core 1 or 
Thomsen-Friedenreich (TN or T) antigen.  
3. In total, 8 O-linked core structures have been described, each resulting 
from the addition of Gal and/or GlcNAc to Tn antigen.  Core 1-core 4 
structures are more common compared to the other core structures. The 
8 core structures are shown in Figure1.10 
4. The core structures can be either sialylated / fucosylated, by the addition 
of SA or Fuc respectively, terminating further extension or they can be 
extended to form linear or branching O-linked chains. These linear and 
branched chains in turn can also be terminated by fucosylation or 
sialylation. 
5. O-linked glycans can be very simple, for example, consisting of a single 
monosaccharide or they can be more complex. In general, O-linked 
glycoproteins tend to be less branched compared to N-linked 
glycoproteins. They are usually composed of simple linear or bi 
antennary chains. 
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Figure.1.10: The eight core structures formed during O-linked glycosylation: 
The core structures are formed by the addition of Gal and GlcNAc to Tn 
antigen. For monosaccharide symbols please see Table 1.1. Adapted from 
(Brooks et al., 2002). 
1.6.6. N- and O-linked chain extension 
The N and O-linked structures described above can be extended by the addition 
of monosaccharides to give two types of glycoprotein chains. Type 1 chain is 
formed by the addition of Gal to a terminal GlcNAc residue by (β1→3) linkage. 
Type 2 chain is formed by the addition of Gal to a terminal GlcNAc by (β1→4) 
linkage and is called a lactosamine unit. Both these chains can be terminated by 
sialylation /fucosylation or can be extended further.  Type 1 and type 2 chains 
are shown in the figure 1.11. 
 
Chapter 1: Introduction   
  41 
 
Figure.1.11: Schematic representation of type 1 and type 2 chains: The chains 
are formed during the extension of N and O-linked glycan chains. For 
monosaccharide symbols please see table 1.1 
1.7. Aberrant glycosylation in cancer 
Glycoproteins play a key role in cell-cell and cell-extracellular matrix adhesion 
and interactions. Glycoproteins function as cell adhesion molecules per se and 
they also modulate the function of receptors of adhesion molecules like 
selectins and integrins which recognize them. Selectins and integrins have been 
described in the section 1.3.11 – 1.3.12. Aberrant glycosylation alters these 
functions and can confer cancer cells with novel properties, for example altered 
invasiveness and metastatic capability (Hakomori, 1996).  While the changes in 
glycosylation reported in malignancy are widespread and complex, they may be 
categorised according to defined themes, described below:  
1. Incomplete synthesis of glycans or synthesis of truncated glycans. 
2. Exposure of Lewis antigens 
3. Increased β1→6 branching of N-linked glycans  
4. Changes in sialylation and fucosylation 
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5. Emergence of HPA-binding glycans. 
1.7.1. Incomplete synthesis of glycans  
As described in section 1.6.5, the first step in the biosynthesis of O-linked 
glycans is the formation of GalNAcα Ser/Thr or Tn antigen. Following its 
synthesis, Tn antigen is either sialylated to form sialyl Tn (which terminates 
further chain extension) or more commonly, it is extended by the sequential 
addition of monosaccharides to form various core structures and further 
extension. Highly specialised enzyme families catalyse each step of O-
glycosylation and these include, among others, members of the ppGalNAc –Ts, 
sialyl transferases and several core transferases.  
Enzymes of O-linked glycosylation show altered level of activity in cancers. 
For example, among the members of the ppGalNAc –T enzyme family (which 
catalyse the first step of O-linked glycosylation) ppGal NAc- T1 and T2, 
believed to be ‘housekeeping’ enzymes, have been detected in normal breast 
epithelial cell lines while, in addition, other members of the ppGalNAc-T 
family, notably T3 and T6, whose expression is normally tightly regulated, are 
detectable in breast cancer cell lines  (Brooks et al., 2007).  Similar changes 
have also been found in colorectal cancers (Kohsaki et al., 2000) and gastric 
carcinomas (Gomes et al., 2009). Increased activity of  α2,3 sialyl transferase 
(ST3Gal I), which catalyses the addition of SA to core 1, is seen in breast 
cancers (Burchell et al., 1999).  Such alteration in the expression as well as the 
activity of these normally highly regulated enzymes results in modification of 
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the usual pathway of glycosylation resulting in the formation of incomplete or 
truncated glycans. 
One such incomplete glycan that has been extensively researched in cancer 
glycobiology is Tn antigen. In normal tissues, Tn antigen is always extended 
and hence, masked. Exposure of Tn antigen is a well-known feature of cancers 
and was described for the first time in breast cancer (Springer et al., 1975). Tn 
antigen exposure is associated with poorly differentiated and metastatic 
carcinomas and hence is considered an established marker of poor prognosis. 
Tn antigen and another truncated glycan, core 1 or Thomsen-Freidenreich  
antigen (T antigen, described in section 1.6.5), have now been shown to be pan 
carcinoma markers present in more than 90% of  all carcinomas (Springer, 
1995).  
Sialyl Tn (N-acetylneuraminic acid α(2→6)-N-acetylgalactosamine) which is 
formed by the sialylation of Tn antigen is also a feature of several cancers. It 
has been described in breast, gastric, oesophageal and colorectal cancers 
(Itzkowitz et al., 1989, Werther et al., 1994, Cho, 1994, Freire et al., 2005).  
1.7.2. Exposure of Lewis antigens 
Lewis antigens are a family of small, fucosylated, histo blood group antigens 
consisting of four members, namely Lewis a (Le
a
), Lewis b (Le
b
), Lewis x 
(Le
X
)
 
and Lewis y (Le
y
).  
Lewis antigens are normally found on erythrocytes. In addition to this, Lewis
a
 
and Lewis
b
 are also found on secretory epithelia like those in the gastro 
intestinal tract. During foetal life, Lewis antigens play a crucial role in 
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embryogenesis and organogenesis. In adults, they are involved in the protection 
of mucosal surfaces and binding of bacteria. In addition to this, Lewis antigens 
are strong binding partners of selectins. Therefore Lewis antigens present on 
neutrophils aid the recruitment of neutrophils and their selectin mediated rolling 
during inflammation as explained in sections 1.3 -1.4 (Sanders and Kerr, 1999, 
Ohyama et al., 1999). As explained in section 1.3, during metastasis, tumour 
cells may employ mechanisms that are similar to those used by leukocytes in 
inflammation. This process is thought to be mediated by Lewis antigens. Lewis 
antigens, when present on cancer cells, may be implicated in cancer cell 
adhesion and transendothelial migration, and thus be functional in metastatic 
mechanisms (Ohyama et al., 1999). Lewis antigens a and x and their sialylated 
counterparts are shown in Figure.1.12. 
 
Figure 1.12.Schematic representation of Lewis antigens, a and x and their 
sialylated forms. R represents linkage to the polypeptide chain. Monosaccharide 
symbols are shown in Table 1.1 
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Lewis antigens and their sialylated forms are synthesised by several cancers. 
Le
y
 and Le
b
 antigen are elevated in breast carcinoma and have been shown to be 
a bad prognostic sign when present in lymph node negative tumours (Madjd et 
al., 2005). Sialyl Le
a
 has been shown to be a prognostic indicator for outcome 
and survival in colorectal cancers (Shimono et al., 1994). Loss of Le
b
 antigen 
has been described in breast cancer and Le
y
 antigen has been associated with 
poorly differentiated cancers of colon, rectum, liver and uterus (reviewed in 
Brooks et al., 2008b).  
1.7.3. Increased branching 
As explained in section 1.6.6., glycoprotein extension often takes place through 
the formation of type 1 and type 2 chains. Type 1 chains are frequently 
extended by the addition of Fuc, GalNAc, SA and Gal residues to give several 
commonly occurring glycoproteins. The Lewis group of antigens, described in 
the previous section, is one such derivative of N-linked glycosylation.  
Malignant transformation usually leads to synthesis of larger N-linked glycans 
which frequently demonstrate increased branching at the trimannosyl core i.e. 
-GlcNAcβ1-6Manαl-6Manβ- (Easton et al., 1991). The β(1→6) branches of tri 
and tetra antennary N-linked glycans are typically attached to polylactosamine 
chains. These polylactosamine chains in turn carry Lewis antigens (Brooks et 
al., 2008b). Increased β(1→6)  branching therefore increases Lewis antigen 
content. As described in the previous section 1.7.2, the presence of increased 
Lewis antigens are associated with enhanced metastatic capability of cancers 
and poorer prognosis. 
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Increased GlcNAc β(1→6)Man  branching has been demonstrated on colon and 
breast cancers. The glycans with increased β(1→6) branching are specifically 
recognised by a lectin (lectins, which are naturally occurring glycan-binding 
molecules, are described in the section 1.8.) isolated from the common bean 
Phaseolus vulgaris (PHA-L). PHA-L binding glycans were reported to be 
significantly increased in clinical specimens of breast and colon cancers and the 
levels correlated with the grading of the tumors (Fernandes et al., 1991). 
Increased β(1→6) branching has also been demonstrated in breast cancers with 
lymph node metastasis and is associated poorer prognosis (Handerson et al., 
2005). 
1.7.4. Altered sialylation 
It has been explained in the section 1.6.5., that sialic acids are often present at 
the ends of glycan chains and the addition of sialic acids terminates further 
chain extension. Sialic acids are negatively charged and play an important role 
in cell to cell communication, cell-extracellular matrix communication, 
adhesion and interaction with cell membrane proteins. 
Altered sialylation is brought about by the alteration of expression or activity of 
sialyl transferases, the enzymes that catalyse addition of sialic acids in specific 
linkages to the glycans chain. Altered activity of sialyl transferases has been 
demonstrated in cancers including breast cancer (Whitehouse et al., 1997, 
Burchell J, 1999 ) and gynaecological cancers (Wang, 2004).  
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1.7.5. HPA binding glycans 
Abnormal glycosylation changes recognised specifically by the lectin Helix 
pomatia agglutinin (HPA) are a well-documented feature of several cancers and 
are described in detail in 1.8.2-6. This type of glycosylation change, and in 
particular, the putative functional role of the glycans in the metastatic cascade, 
are of particular interest to this thesis. Hence, a brief description of lectin 
chemistry, HPA and its binding partners, HPA binding glycans in cancers in 
general and breast cancer in particular is given below. 
1.8. Lectin chemistry 
Lectins are proteins or glycoproteins that bind to carbohydrates in a selective 
and specific fashion.  They are ubiquitous in nature and present in micro-
organisms, invertebrates, vertebrates and plants. Lectins are multivalent (i.e. 
they possess multiple carbohydrate binding sites) and are of non-immune 
origin. Hundreds of purified lectins are available commercially, many from 
plants sources, and with differing and often incompletely defined carbohydrate-
binding properties. Like HPA, they have been utilised widely in glycobiology 
research. They are of particular interest in the study of abnormal glycosylation 
in cancers because they possesses highly selective binding pattern to specific 
glycans for e.g. abnormal glycans present on cancer cell surface.  
Human lectins are classified in to 5 lectin families which include C-Type 
lectins, I-Type lectins, S-Type lectins or Galectins and P-Type and L-Type 
lectins. Among these 5 lectin families, the C-Type lectins which include 
selectins and I-Type lectins which include members of the immunoglobulin 
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superfamily like ICAM-1 and PECAM are of particular relevance to this thesis  
(see also sections 1.3.13 and (Brooks et al., 2002) . 
1.8.1. HPA and its binding partners  
Helix pomatia agglutinin (HPA) is a glycoprotein that is derived from albumin 
gland of the edible Roman snail, Helix pomatia. HPA is structurally a hexamer 
and displays a binding specificity to the monosaccharide, α-D-GalNAc 
(Hammarstrom and Kabat, 1969, Sanchez et al., 2006).  In addition to GalNAc, 
it also binds to the monosaccharides α-D-GlcNAc and α-Gal, but with lower 
affinity. In experimental systems, HPA identifies and specifically binds 
terminal GalNAc residues in normal substances including blood group A 
antigen. It also recognises cancer-associated glycans including Tn antigen 
(discussed in Sections1.6.4 and 1.7.1) and Forssman antigen 
(αGalNAc1→3αGalNAc), a cancer-associated epitope present in glycolipids 
(Lescar et al., 2007). The recognition by HPA of (as yet incompletely defined) 
glycans synthesised by cancers has been described as being associated with 
metastasis and poor patient prognosis, as described in section 1.8.3 and is a 
particular focus of this thesis.  
1.8.2. HPA binding glycans and cancer prognosis 
HPA binding glycans on cancer cell surface as a marker of poor prognosis was 
described for the first time by Leathem and Brooks in 1987.  They conducted a 
retrospective study of 176 patients who had in undergone mastectomy for 
primary breast cancer and labelled the tumour samples of these patients for 
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HPA binding glycans. Positive or negative HPA binding in the tumour samples 
was compared to patient prognosis defined in terms of disease free interval 
post- surgery, 5 year and 10 year survival rates. It was shown that patients with 
positive HPA-binding had shorter survival periods, with an average 5 year 
survival rates for HPA-positive patients being 40% and 10 year survival rates 
being 35%. This was in comparison to 5 year survival rate of 90%, and 10 year 
survival rates of 75% in non-HPA-binding cases. This study thereby provided 
evidence that presence of HPA binding glycans correlated with shorter disease 
free interval and poorer prognosis. 
The same researchers continued with an investigation of the association 
between HPA binding glycans and positive lymph node metastasis in breast 
cancer in an extended retrospective study of 373 patients (Brooks and Leathem 
,1991). Subsequently, a multivariate analysis was also carried out in the same 
patient group to analyse the relationship between HPA binding glycans and 
other, well established prognostic indicators including lymph node status, 
patient age at diagnosis, tumour size, histological grade and S-phase fraction 
(Brooks et al, 1993). Both studies established a strong correlation between HPA 
binding glycans and lymph node metastasis. In addition to this, as a prognostic 
factor, the presence of HPA binding glycans was demonstrated to be 
independent of all the other prognostic factors tested. Hence, HPA binding 
glycans emerged as vital indicators of metastatic potential and poor patient 
prognosis in breast cancer (Brooks and Leathem, 1991, Brooks et al., 1993). 
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Following on from these pioneering studies, abnormal HPA binding glycans as 
a hallmark of cancers and a feature of poor prognosis has been subsequently 
confirmed by several other independent studies both for breast cancer (Fenlon 
et al., 1987, Fukutomi et al., 1989, Alam et al., 1990, Thomas et al., 1993, 
Noguchi et al., 1993, Chen et al., 2007) and for cancers of the oesophagus 
(Yoshida et al., 1993), stomach (Kakeji et al., 1991, Maehara et al., 1995), 
colon (Schumacher and Adam, 1997), lungs (Laack et al., 2002), prostate 
(Shiraishi et al., 1992) and malignant melanomas (Kjonniksen et al., 1994, 
Thies et al., 2001) .  
1.8.3. Characterisation of abnormal HPA binding glycans 
Despite a strong body of evidence linking HPA binding glycans to cancers in 
general and metastatic cancers in particular as described in the previous section, 
the exact nature and identity of HPA binding glycans remains undefined. Some 
early reports linked the metastatic potential of abnormal HPA binding glycans 
first described by Leathem and Brooks in 1987 to the presence of Tn antigen 
(Springer, 1989) and to blood group A substance (Grundbacher, 1987), both 
established binding partners of HPA. However, immunohistochemical studies 
utilising HPA and monoclonal antibodies reactive with Tn antigen and blood 
group A substance in breast cancer specimens has established that while these 
two epitopes are present in a minority of the cancer specimens and are promptly 
recognised by HPA, in majority of the specimens, HPA also identified an 
additional  diverse group of abnormal glycans with a markedly different 
labelling and distribution pattern compared to blood group A substance and Tn 
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antigen (Brooks and Leathem, 1995). Furthermore, western blot analyses 
comparing HPA binding glycoproteins with blood group A- and Tn antigen-
bearing glycoproteins in breast cancer specimens and colon cancer cell lines 
indicated that the unidentified epitope bound by HPA represents a global 
glycosylation abnormality that is different in distribution to both Tn antigen and 
blood group A substance (Brooks and Leathem, 1995, Saint-Guirons et al., 
2007).   
Extraction and purification by affinity chromatography of cell membrane 
glycoproteins from breast cancer cell lines and clinical breast cancers 
specimens has shown that the HPA binding glycans in these glycoconjugates 
contain GalNAc and sialic acid. Similar experiments in colorectal cancer cell 
lines followed by competitive inhibition studies with GalNAc, GlcNAc and 
sialic acids has shown that the glycan- HPA interaction in these cells occurs 
through binding of HPA to glycoconjugates consisting of GalNAc, GlcNAc and 
sialic acid and their location on the glycan chain is either terminal or sub 
terminal (Dwek et al., 2001, Saint-Guirons et al., 2007).  
Protein elution from HPA affinity chromatography and subsequent 
characterisation of these proteins by proteomic analysis has revealed that HPA 
binding proteins include molecules like integrin α6, integrin α5 and annexins, 
which are involved in cell adhesion and migration, filament proteins like α-
tubulin, β-tubulin, cytokeratins and actin which are involved in remodelling, 
and HSP-70, HSP-90, HSP-96 and TNFR-1 which are involved in antiapoptotic 
pathways. While several of these molecules have been associated with cancer 
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and might be subject to abnormal glycosylation and hence recognised by HPA, 
the exact mechanism of binding of these complexes to HPA is still unclear. 
Some of these molecules might bind HPA directly through the lectin-glycan 
interactions described earlier, while others might bind HPA indirectly by 
forming complexes with HPA binding glycoproteins, for example, by binding 
O-GlcNAc glycoproteins in the cytoplasm (Saint-Guirons et al., 2007).  
1.8.4. Functional role of HPA binding glycans in the metastatic cascade 
It is clear from the discussions in sections 1.8.2.that exposure of HPA binding 
glycans on cancer cell surface both in breast cancers and several other cancers 
is a prominent feature of aggressive and metastatic cancers and a well-
recognised marker of poor prognosis. As a consequence of this association, 
studies to explore if HPA binding glycans played a part in any, or all, of the 
steps of metastatic cascade were initiated. 
Brooks and Hall (2002) carried out a matrigel invasion assay to investigate 
whether HPA binding glycans were involved in the adhesion of cancer cells to 
the vascular basement membrane and subsequent invasion through it (Brooks 
and Hall, 2002). This process of adhesion to, and invasion through, basement 
membrane is a vital component of both intravasation in to blood vessels and 
extravasation out of blood vessels during blood borne metastasis and is 
described in detail in sections 1.2.1-1.2.5. 
In this study, seven breast epithelial cell lines were selected to include normal 
breast epithelial cells along with a range of malignant cells to represent a 
disease spectrum varying from primary, minimally invasive breast cancers to 
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aggressive, metastatic breast cancers. The HPA binding profiles of these cell 
lines had been well characterized previously and was found to correlate with 
HPA binding glycan profile present in clinical breast cancer specimens (Brooks 
et al., 2001). The cells were assessed for their ability to adhere to, and invade 
through basement membrane matrix in the presence of HPA binding glycans 
and this was compared to adhesion and invasion of cancer cells after the 
inhibition of HPA binding glycans. There was no difference in the ability of the 
cancer cells to adhere or to invade through basement membrane in the presence 
or absence of HPA inhibition in this study for all the seven cell lines studied 
thereby indicating that HPA binding glycans were unlikely to be involved in 
this aspect of the metastatic cascade.  
A further pilot study then investigated the role of HPA binding glycans in 
another crucial step of the metastatic cascade namely, adhesion of cancer cells 
to vascular endothelial cells lining the microvasculature and their subsequent 
transmigration across the vessels (adhesion and transendothelial migration of 
cancer cells has been described in detail in sections 1.3-1.5). The adhesive 
interactions of six breast cancer epithelial cell lines in the presence and absence 
of HPA binding glycans to cultured endothelial cells lines HMMEC7 and 
HUVEC were studied using a rocking adhesion assay system. Inhibition of 
HPA binding glycans was found to significantly reduce the adhesion of breast 
cancer cells to the endothelial cell layer in this study thereby suggesting that 
HPA binding glycans present on cancer cell surface might contribute to 
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adhesion and transendothelial migration of these cells during metastasis 
(Valentiner et al., 2005).  
1.8.5. Role of HPA binding glycans in adhesion and transendothelial 
migration step of the metastatic cascade 
The very limited pilot study by Valentiner et al described above in section 
1.8.4. was further expanded by Dr. Hannah Lomax-Browne, one of the PhD 
students in our group to investigate the adhesion and transmigration step of the 
metastatic cascade by utilising a model of breast cancer metastasis consisting of 
breast cancer cell lines and human microvascular endothelial cell lines (Lomax-
Browne, 2009). The 7 breast epithelial cell lines employed in this model 
included HMT3522 derived from normal breast and 6 breast cancer cell lines 
namely BT474, MDA MB 435, MDA MB 468, ZR751, MCF7 T47D and 
DU4475. The microvascular endothelial cell lines were human brain 
microvascular endothelial cells (HBRMEC), human lung microvascular 
endothelial cell line (HLMEC), human peripheral lymph node endothelial cell 
line (HPLNEC) and human mesenteric lymph node endothelial cells 
(HMLNEC) derived from human brain, lung and lymph nodes respectively. 
However, due to technical faults with the microvascular endothelial cell lines, 
the breast cancer metastasis model used by Dr. Lomax-Browne was altered to 
incorporate the primary endothelial cells, human umbilical vein endothelial 
cells (HUVECs). Furthermore, the adhesion assays were further developed and 
optimised to incorporate live cell imaging.  
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Three breast cancer cell lines were utilized in the project described in this thesis 
and these were BT 474, ZR 75 1 and MCF 7. The process of adhesion and 
transendothelial cell migration of these 3 cell lines was studied by performing 
adhesion assays to a monolayer of commercially available, primary endothelial 
cells, human umbilical vein endothelial cells (HUVECs).  
The three breast cancer cell lines BT 474, ZR 75 1 and MCF 7 were a kind gift 
from the genomic instability research group at Oxford Brookes University and 
HUVECs were procured from Lonza, UK. The three breast cancer cell lines 
utilized in this project were selected to represent a spectrum of behavioural 
patterns seen in breast cancers ranging from primary, non-metastatic tumours to 
aggressive, metastatic tumours. BT 474 is a breast cancer epithelial cell line 
derived from a non-metastatic primary  ductal carcinoma of the breast 
(Lasfargues et al., 1978). ZR 75 1 is derived from malignant ascites secondary 
to ductal carcinoma of the breast (Engel et al., 1978). MCF 7 was originally 
derived from a malignant pleural effusion secondary to infiltrating ductal 
carcinoma of the breast (Soule et al., 1973). The HPA binding glycan profiles 
of the cell lines have been carefully documented and are consistent with their 
derivation. Thus, the metastatic MCF 7 cells synthesize high levels of HPA 
binding glycans, ZR 75 1 cells synthesize moderate levels of HPA binding 
glycans and BT 474 cells synthesize negligible levels of HPA binding glycans 
(Brooks et al., 2001). HPA has been clearly shown to recognize a similar 
profile of glycosylated proteins in these cell lines and clinical breast cancer 
samples and hence, these cells form appropriate tools for the study of breast 
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cancer cell behaviour during metastasis (Dwek et al., 2001, Brooks et al., 
2001).  
HUVECs are primary, macro vascular endothelial cells commonly obtained by 
collagenase digestion of the umbilical vein from freshly delivered placenta. The 
cells possess morphological and immunological properties similar to other 
macro vascular endothelial cells in the body (Gimbrone et al., 1974, Jaffe et al., 
1973). They are commonly utilised in the study of adhesion and 
transendothelial migration in both cancer cells and leucocytes. One of the main 
limitations of using HUVECs in the study adhesion and transendothelial 
migration is that HUVECs are not derived from a site which is physiologically 
relevant to cancer cell metastasis. The molecular interactions during adhesion 
and transendothelial migration in cancer cell metastasis and the analogous 
process involving leucocytes during inflammation occur predominantly in the 
terminal capillaries of the body where the cancer cells or leucocytes interact 
with the micro vascular endothelial cells lining the capillaries. However, 
HUVECs are commonly employed as a substitute to micro vascular endothelial 
cells in the study of adhesion and transendothelial migration in both cancer 
cells and leucocytes because they are relatively inexpensive and easy to grow in 
comparison to their micro vascular counterparts. In addition to this, HUVECs, 
when grown as primary cultures, also express a range of relevant adhesion 
molecules e.g. selectins and integrins involved in the process of adhesion and 
transendothelial migration, and expression of these key molecules is usually 
lost in immortalised cell lines. 
Chapter 1: Introduction   
  57 
The optimisation of model of breast cancer metastasis to incorporate HUVECs 
and to facilitate live cell imaging and the study of adhesion and transendothelial 
migration step of the metastatic cascade by utilising this are the focus of the 
research project described in this thesis. 
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1.9. Aims of the project 
The aims of the project are as follows. 
 To optimise a confocal microscope compatible rocking adhesion assay 
system to facilitate live cell imaging 
 To determine the optimum duration of rocking to be utilised for the 
rocking adhesion assays.  
 To employ the rocking adhesion assay system to evaluate the role of 
HPA binding glycans in the adhesion of breast cancer epithelial cells to 
endothelial cells 
 To study the post adhesive behavior of the cancer cells using confocal 
microscopy and scanning electron microscopy  
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2.1. Introduction  
The experiments described in this thesis utilise three breast cancer cell lines BT 
474, ZR75 1 and MCF 7 and the endothelial cells HUVECs. 
In the following sections, a brief description of the techniques employed for 
routine culture and maintenance of the cancer and endothelial cells used in this 
project is given along with a brief outline of the important quality control steps. 
Detailed description of individual experiments is then given in the chapters 
pertaining to those experiments.  
2.2. Routine cell culture techniques: 
2.2.1: Retrieving cells from liquid nitrogen storage 
Cryovials containing frozen cell suspension were removed from liquid nitrogen 
storage and sterilised with 70% ethyl alcohol. The cell suspension was thawed 
by rolling the cryovials in the palm of the hand. The thawed cell suspension 
from each vial was pipetted out in to a 15ml Falcon tube containing 5ml of 
fresh, warmed culture media. The different cell culture media utilised for the 
culture of the various cells types is detailed in Table 2.1. The Falcon tubes were 
centrifuged in a Jouan B4 centrifuge at 260 ×g for 10 min if retrieving breast 
cancer epithelial cells and 7 min if retrieving endothelial cells. The supernatant 
was discarded and the tubes were flicked several times to loosen the pellet of 
cells. The cells from each tube were resuspended in 7ml of cell culture media 
and transferred to a 25cc tissue culture flask. The cells were incubated in a 
37oC, 5%, CO2 incubator. 24 h after retrieval, spent culture media was pipetted 
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out from the flasks to remove any dead cells and replaced with fresh cell culture 
media to facilitate the recovery of the remaining cells. The cells were grown to 
confluence and were either transferred to 75cc flasks or sub cultured as 
described in section 2.2.3. 
2.2.2: Routine maintenance of cell cultures:  
The breast cancer epithelial cells and endothelial cells were cultured in 25cc
 
or 
75cc tissue culture flasks. Cell culture media was routinely changed every 48-
72 h by pipetting out old media and replacing it with fresh, warmed media (7ml 
for 25cc flasks and 15ml for 75cc flasks) until the cells were ready to be sub 
cultured. The cell culture media used for each cell type and the relevant 
supplements is listed in Table 2.1. 
2.2.3: Routine sub culturing of the cells:  
Cells were sub cultured when the confluence of the cells was between 85-
100%. Confluence was estimated by visual assessment of the percentage of the 
culture surface covered by cell growth. For example if half of the culture 
surface was covered by cell growth, then confluence was taken to be 50%, if the 
whole surface was covered by cells, then 100% and so on. 
To subculture cells, spent media was pipetted out and discarded from culture 
flasks and the cells were washed thoroughly with phosphate buffered saline 
(PBS, pH: 7.2-7.4, Gibco, UK). PBS was discarded and the cells were rinsed 
thoroughly with a solution of porcine trypsin in EDTA (Gibco, UK), (1ml for 
25cc flasks and 2ml for 75cc flasks). Breast cancer cells were trypsinised using 
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0.05% w/v of trypsin/EDTA solution and after removing the trypsin, cells were 
incubated at 37
0
C for 7-10 minutes. A similar method of trypsinisation was 
utilised for HUVECs but using 0.025% w/v solution of trypsin/EDTA solution 
and an incubation time of 2-5 min.  The trypsin was inactivated and the cells 
dissociated from the culture flasks by rinsing the culture surface with cell 
culture media. The cell suspension was pipetted up and down several times to 
disaggregate clusters of cells and the cells were seeded into tissue culture flasks 
at a ratio of 1:5-1:10.  
Fresh vials of HUVECs were retrieved from liquid nitrogen prior to each set of 
experiments. The cancer cells were grown for a maximum of 5 passages and 
HUVECs were grown for a maximum of 3 passages to minimise phenotypic 
variation. 
2.2.4: Freezing down cells in liquid nitrogen storage:  
Cell suspension was obtained from confluent 75cc flasks as described in section 
2.2.2-3. The cell suspension was centrifuged at 1200rpm in a Jouan B4 
centrifuge at 260 ×g for 10 min (7 min for endothelial cells). Supernatant was 
discarded and the cell pellet was loosened by flicking the tube. The cells were 
suspended in 2ml of 1:9 solution of dimethyl sulphoxide in culture media and 
transferred to 2x 1.5 ml cryovials. The cryovials were placed in -20
0
C freezer 
for 2 hours, -80
0
C freezer overnight and were then transferred to liquid nitrogen 
store the next morning. 
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Table 2.1: Media and supplements used for cell culture 
Cells Media Supplements 
BT 474 IMDM  
(PAA, UK) 
Heat inactivated FCS-13% v/v  (Sigma, UK) 
L-Glutamine-2Mm (Gibco, UK) 
1%v/v penicillin and streptomycin solution (Sigma, UK) 
ZR 75 1 RPMI-1640 
(Gibco, UK) 
Heat inactivated FCS-10%v/v (Sigma, UK) 
 L-Glutamine-2mM (Gibco, UK) 
Sodium pyruvate-1mM (Sigma, UK) 
1%v/v penicillin and streptomycin solution (Sigma, UK) 
MCF  DMEM:F-12 
(Gibco, UK) 
Heat inactivated FCS-13%v/v (Sigma, UK) 
L-Glutamine-2Mm (Gibco, UK) 
1%v/v penicillin and streptomycin solution (Sigma, UK) 
HUVECs EBM-2 
(Clonetics, 
Lonza, UK) 
Components of single quotes supplement pack (Clonetics, Lonza, 
UK) added to 500mls of media. Components consist of : 
-Hydrocortisone-2mls 
-Human fibroblast derived growth factor-B (hFGF-B) -0.5mls 
-Vascular endothelial growth factor (VEGF) -0.5mls 
-R3-insulin derived growth factor -1(R3-IGF-1) -0.5mls 
-Ascorbic acid-0.5mls 
-Heparin-0.5mls 
-Human epidermal growth factor (hEGF)-0.5mls 
-Foetal bovine serum-10mls 
-Gentamycin and amphotericin(GA-1000) solution-0.5mls 
 
2.3. Quality control steps: 
2.3.1 Viability testing of the cells:  
Cell cultures were routinely tested for the percentage of viable cells prior to 
utilizing them for experiments using the stain erythrosin-B. Erythrosin-B is a 
non-toxic and highly effective stain for viability testing particularly for cells in 
monolayer cultures. Erythrosin-B is a vital exclusion stain because it is 
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excluded by live cells which possess an intact plasma membrane. Viable cells, 
therefore, appear clear when stained with the dye. Erythrosin-B however, 
diffuses into dead cells which have lost the integrity of their plasma membrane 
and makes the cells appear pinkish red when viewed using a light or fluorescent 
microscope (Krause et al., 1984). 
 For viability testing, cell suspension was obtained as described in section 2.2.3. 
100µl of the cell suspension was mixed with 100 µl of 0.8mg/ml working 
solution of erythrosine-B (Sigma, UK) in Hanks balanced solution (Sigma, 
UK). 10 µl of this mixture was placed on a haemocytometer slide and a cell 
count was obtained. The percentage of live and dead cells was noted and the 
cell suspension was used in experiments only if the percentage of viable cells 
was above 95%. 
2.3.2. Testing for mycoplasma contamination:  
All the cell cultures were periodically tested for mycoplasma contamination by 
using the DNA stain Hoechst 33258 (Sigma). Hoechst 33258 stains nuclei of 
cells and mycoplasma and when viewed using a fluorescence microscope and 
UV filter, DNA excitation occurs at 360-365nm and the stained nuclei and 
mycoplasma fluoresce brightly. When cell cultures are stained with Hoechst 
33258, clean cultures will demonstrate only clear, brightly fluorescent nuclei 
with uniformly black extra nuclear and intercellular background. Infected 
cultures on the other hand will display mycoplasma which appear as brightly 
fluorescent, extra nuclear and inter cellular bodies with uniform morphology 
(Chen, 1977). 
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To carry out testing for mycoplasma contamination, a cell suspension was 
obtained by trypsinisation as described in section 2.2.3. Cells were seeded at 
optimum seeding densities in 4-well chamber slides (Sigma, UK). Once the 
cultures reached a confluence of 60-70%, media was aspirated and the cells 
were washed with 3 changes of PBS. The cells were fixed at room temperature 
using 25% v/v glacial acetic acid in methanol for 10 min and washed again with 
3 changes of PBS. Chamber slides were then placed in the dark and the cells 
incubated with a 0.05µg/ml solution of the stain Hoechst 33258 (Sigma) in FCS 
free media for 10 min. The cultures were then washed three times with sterile 
distilled water and the chambers were removed from the slide. The slide was 
mounted using Citifluor anti-fade mountant (Agar scientific) with a coverslip. 
The coverslip was sealed using clear nail varnish and the slide was viewed 
using an Axioplan Pol universal fluorescence microscope using a 40x objective 
and UV filter.  
DNA excitation occurred at 360nm and emission at 490-500nm and in all the 
cultures tested. There was no evidence of mycoplasma contamination as 
evidenced by the presence of brightly fluorescent nuclei with no extra nuclear 
fluorescent bodies.  
2.3.3  Karyotyping of the cells 
The endothelial cells and cancer cell lines utilized in this project were subjected 
to karyotyping prior to commencing this project with the help of colleagues in 
the genomic instability research group at the university. This process was 
performed to establish the karyotype of all the cells utilised for this project and 
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to ascertain that there was no modification of the cells from their standard 
reported karyotype. A detailed description of the procedure employed for 
karyotyping is beyond the scope of this thesis and can be found in standard text 
books [for example (Tirulinai, 2012)].  
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3.1. Introduction  
During metastasis, cancer cells detach from the primary tumour mass, gain 
entry into the systemic circulation by a process referred to as intravasation, get 
carried via the blood stream to target organs where they adhere to and 
transmigrate across the endothelial cells lining the microvasculature of the 
target organs to form secondary tumours (as described in Chapter 1, sections 
1.2.1-1.2.5). While cancer metastasis has been described as a cascade and 
cancer cells have to complete each step of the cascade in a sequential manner to 
be able to successfully metastasise, one of the key steps in cancer cell 
metastasis appears to be adhesion of cancer cells to endothelium and 
transendothelial migration. Early clinical studies by Tarin et al (1984)  
demonstrated that a major proportion of cancer cells which have reached the 
systemic circulation having successfully completed the preceding steps of the 
metastatic cascade fail to form metastatic tumours (Weiss, 2000). As described 
in section 1.2.5, whilst mechanical entrapment of cancer cells in the small-bore 
capillaries of target organs may contribute to the seeding of metastatic deposits, 
there is increasing evidence that cancer cells utilise highly selective, organ 
specific mechanisms to adhere to the endothelial cells lining the capillaries of 
the target organs and progress to transmigration and formation of secondary 
deposits. The behaviour of cancer cells during adhesion and transmigration is 
thought to be similar to the behaviour of leucocytes during inflammation as 
described in section 1.3. Adhesion and transendothelial migration in leucocytes 
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has been studied in great detail and is well understood. The analogous process 
in cancer cells however is still poorly understood. 
Two adhesion assay systems, namely static adhesion assay systems and flow 
assay systems are traditionally utilised to study the process of adhesion and 
transendothelial migration in both cancer cells and leucocytes. Both assay 
systems utilise a monolayer of endothelial cells mimicking the capillary 
endothelium onto which the cancer cells or leucocytes are added. Whilst in the 
static assay system the adhesive interactions between the two cells are allowed 
to take place under static conditions, in the flow assay systems, the cancer cells 
or leucocytes are caused to sweep over the endothelial cell layer and the 
adhesive interactions occur under conditions of flow.  
Static adhesion assay systems have the advantage of being simple to set up and 
easy to perform without the need of specialist equipment. However, their main 
disadvantage is that they do not mimic physiological conditions of dynamic 
flow which produces shear forces that are thought to be vital in up regulating 
important adhesion molecules. Flow assay systems have the advantage of 
closely mimicking physiological conditions and allow for precise control of the 
experimental variables. For example, in the study of leucocyte adhesion and 
transendothelial migration, flow assay systems can be precisely modulated to 
produce a shear stress in the range of 1-6 dyn/cm
2 
which is believed to be the 
physiological range of shear stress for leucocyte recruitment at post capillary 
venules (Toetsch et al., 2009)
 
. Despite this advantage however, flow assays 
require specialist equipment and hence can be expensive. They can also be time 
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consuming particularly when multiple replicates of the assay are required for 
obtaining quantitative data. 
An alternative assay system to the static and flow assay system is a semi static 
adhesion assay system. In the semi static assay system, the cancer cells are laid 
on a monolayer of endothelial cells like the static adhesion assays, but 
conditions of flow are created by rocking the co culture of cells on a rocking 
platform. Preliminary experiments employing the semi static adhesion system 
were carried out initially by Valentiner et al to study the adhesion of breast 
cancer cell lines MCF 7, ZR 75-1 and DU 4475 to human umbilical vein cells 
and human mammary micro vascular endothelial cells by (Valentiner et al., 
2005). Subsequently, the rocking adhesion assay system was further developed 
and optimised by Dr. Chloe Osborne one of the PhD students  in our group 
(Osborne, 2004). In brief, the rocking adhesion assays optimised by Dr. 
Osborne consists of the following steps:  
 A monolayer of endothelial cells is cultured on cover slips placed in 24 
well plates. Prior to the assay, the endothelial cells are pre stimulated 
with TNFα for 2 h to up-regulate adhesion molecules.  
 The cancer cells are labelled with the fluorescent dye, 8-
hydroxypyrenetrisulphonic acid (PTS) to aid their differentiation from 
endothelial cells once adhesion had taken place. The cancer cells are 
then laid on the endothelial cell monolayers in the 24 well plates and the 
plates are rocked to and fro on a rocking platform placed in a 37
o
C CO2 
incubator for 2 h.  
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 At the end of 2 h, the cover slips are washed to remove any non-
adherent cancer cells, the cells are then fixed and the adherent cancer 
cells are counted using a fluorescence microscope.  
This rocking adhesion assay system was utilised for many of the experiments 
described in this thesis because of the following advantages 
 The assay is quick to set up and simple to perform. 
 It facilitates multiple repetitions of the experiment and can be performed 
without the need of any specialist equipment. 
 The adherent cancer cells can be visualised and counted to perform both 
qualitative and quantitative analysis of the results. 
Prior to using the rocking adhesion assay for experiments described in this 
thesis, two main aspects of the assay were optimised. The optimisation 
experiments are described below.  
3.1.1. Optimisation of rocking adhesion assay system for live cell imaging. 
In the original rocking adhesion assay described in section 3.1., rocking to bring 
about adhesion of cancer cells to endothelial cell monolayer was followed by 
fixing the cancer cells for the purposes of imaging. While fixation is widely 
utilised in both plant and animal biology, it is known to produce adverse effects 
on the cells including degradation of nucleic acids, bleaching of lipids and 
denaturation of proteins (Meade et al., 2010). In addition to this, experimental 
factors like choice of fixative, technique used and time of fixation all have an 
impact on the final results. Moreover, one of the aims of the work described in 
this thesis was to image the interactions between living cancer cells and 
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endothelial cells over timed assays using high resolution confocal microscopy. 
Since the initial development of the assay, a wide range of confocal microscope 
compatible cell culture devices that facilitate high resolution, live cell 
microscopy have become widely available. Hence the rocking adhesion assay 
system was developed to incorporate confocal microscope compatible dishes to 
enable live cell imaging. Experiments described here, were performed to 
determine whether these were suitable for use in the rocking adhesion assay 
3.1.2. Determining the time of rocking to obtain optimum number of adherent 
cancer cells 
The second aspect of the assay system that needed further optimisation was the 
total period of rocking to be employed in order to produce maximum adhesion 
of cancer cells to the endothelial monolayer to facilitate both quantitative and 
qualitative analysis of the results. Previous assays, described in section 3.1., had 
employed an arbitrarily chosen time of 2 hours. 
3.2. Materials and methods. 
Components of the rocking adhesion assay system are illustrated in Figure 3.1 
3.2.1 Optimisation of rocking adhesion assay for live cell imaging 
1. Prior to the assay, confocal microscope compatible ibidi µ-
dishes (35mm, high, Thistle scientific, UK) were coated with 1 ml of 
0.2% v/v bovine gelatine (Sigma, UK) in phosphate buffered saline for 
30 min.   
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2. A cell suspension of HUVECs was obtained by trypsinisation as 
described in Chapter 2, section 2.2.3. The cells were seeded at a density 
of 1.5x 10
5
 to 2x10
5
 cells /dish.  
3. 2 ml of fresh, warmed, EBM-2 media with growth supplements 
(as detailed in Chapter 2, Table. 2.1.) was added to each dish and the 
dishes were incubated in a 37
0
C, 5% CO2 incubator. Media was changed 
daily as described in Chapter. 2, section 2.2.2 until a confluent 
monolayer of endothelial cells with no gaps in the cell layer was 
obtained in each dish. 
4. On the day of the assay, spent culture media was aspirated from 
ibidi dishes and 1ml of warmed, TNF-α in EBM-2 media at a 
concentration of 10 ng/ml was added to each dish. The dishes were 
incubated in a 37
0
C, 5% CO2 incubator for 2 h. 
5. At the end of 2 h, the TNF-α solution was replaced with 2 ml of 
fresh EBM-2 media/dish. The dishes were rocked on a rocking platform, 
(shown in Figure 3.2c) placed in a 370C, 5% CO2 incubator for 2 h. At 
the end of 2 h, the dishes were removed from the rocking platform and 
the cells were washed with 3 changes of PBS. 2 ml of fresh EMB-2 
media with supplements was added to each dish and the dishes were 
imaged using Zeiss confocal microscope (458 nm laser, 475 LP filter 
and 10x plan-Neofluar objective) to assess the integrity of the 
endothelial monolayer. Each repeat of the assay was carried out by 
using 2 ibidi dishes and the assay was repeated 3 times. 
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6. The other component of the rocking adhesion assay namely the 
breast cancer epithelial cell lines were tested for the presence of surface 
HPA binding glycans. Cancer cell suspension was obtained as described 
in Chapter 2, section 2.2.3. 1 ml of cell suspension was placed in an 
ibidi dish and the cells were allowed to adhere to the culture surface for 
12 hours. 10µg/ml of HPA FITC (Sigma Adrich, UK) was added and 
the cells were incubated for 2 h. The cells were then washed with 3 
changes of PBS and imaged using Zeiss confocal microscope with 458 
nm laser, 475 LP filter and 25x plan-Neofluar objective. 
3.2.2 Determination of duration of rocking 
1. To determine the optimum duration of rocking, MCF-7 and ZR 75-1 
cells were cultured to obtain confluent flasks of cells as described in 
section 2.2.3. and endothelial cells were cultured in ibidi dishes as 
described in section 3.2.1. ( Represented in figures 3.1a,b.) 
2. Cancer cells were incubated overnight with a 10 mg/ml solution of 
the fluorescent dye 8-hydroxypyrenetrisulphonic acid (PTS) (Sigma, 
UK) in cell culture media. 
3. To perform the assay, HUVEC cells in ibidi dishes were pre 
incubated with10 ng/ml of TNF-α in EBM-2 media. 
4. The PTS solution was aspirated from the culture flasks containing 
cancer cells, cells were washed in 5 changes of PBS and trypsinised 
to obtain a cell suspension. 
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5. TNF-α solution was aspirated from ibidi dishes and replaced with 2 
ml of fresh EBM-2 media. 2x10
5 
cancer
 
cells were added to each 
dish and the dishes were rocked on the rocking platform (figure 
3.1c), for a defined time period. The time points tested were 5 min, 
15 min, 30 min, 45 min, 1 h, 1.5h and 2 h.  
6. At the end of rocking for each time point, the dishes were washed 
with 3 changes of warmed PBS to remove any non- adherent cancer 
cells. The dishes were placed in an incubator after the addition of 
fresh EBM-2 media. The dishes were then removed one by one from 
the incubator to be imaged using Zeiss confocal microscope using a 
10x plan-Neofluar objective and 458 nm laser and 475 LP filter. 
Imaging of all the dishes was completed within 30 min from the end 
of adhesion assays. 
7. To determine the optimum duration of rocking 4 ibidi dishes were 
set up for each time point tested, 2 dishes for MCF 7 cells and 2, for 
ZR 75 1 cells. For a schematic representation, please see figure 3.2.  
The experiments were repeated three times for each time point of 
rocking tested. This gave a total of 6 dishes per time point for MCF 
7 cells and 6 for ZR 75 1.  
8. From each dish, 15 random images were captured giving a total of 
90 images for each time point tested per cell line. The total number 
of adherent cancer cells in each of the 90 images was counted 
manually.  
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3.3. Results: 
The result of the rocking adhesion assays with HUVECs alone, for optimisation 
to carry out  live cell imaging (described in section 3.2.1), is shown in Figure 
3.3. The endothelial monolayer is intact with no apparent detachment of 
HUVECs indicating that ibidi culture dishes form appropriate devices for the 
culture of HUVEC cells for rocking adhesion assay and HUVEC cells cultured 
in these dishes can withstand the shear forces produced during rocking with no 
loss of integrity of the endothelial monolayer. 
A sample photomicrograph of the HPA binding glycan staining with HPA 
TRITC is shown in figure 3.4. Abundant bright red fluorescent staining with 
HPA TRITC shows that MCF 7 cells synthesize high levels of HPA binding 
glycans. 
The results of rocking adhesion assay with MCF 7 cells over different time 
periods are shown in Table. 3.1 and represented graphically in Figure 3.7. 
Sample images depicting the adhesion of MCF 7 cells to endothelial monolayer 
over different time points is shown in figure 3.5.The total number of adherent 
cancer cells at the end of 5 min, and 15 min of rocking were 440 and 878 
respectively. At the end of 30 min of rocking, there was a sharp increase in the 
number of adherent cancer cells with a total of 2524 cancer cells adhering to 
endothelial cell monolayer. At subsequent time points of 45 min, 1 h, 1 h30 
min, there was a steady increase in the number of cancer cells with the time of 
rocking with a total number of adherent cancer cells being 2556, 2937 and 3689 
at these time points respectively. There was no further significant increase in 
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the number of adherent cancer cells beyond 1 h30 min of rocking with the 
number of adherent cancer cells at the end of 2 h being 3706 in comparison to 
3689 cancer cells at the end of 1 h30 min of rocking. In addition to this, 
continued rocking beyond 2 h resulted in the rocking platform getting 
overheated and resulted in the detachment of cancer cells.  
The results of rocking adhesion assay with different periods of rocking for ZR 
751 cells was similar to results obtained with MCF 7 cells. Sample images of 
adherent ZR 75 1 cancer cells are shown in figure 3.6.  The results are shown in 
Table.3.2 and represented graphically in Figure 3.7.  At the end of 5 min of 
rocking, there were 479 adherent cells gradually increasing to 838, 1921, 2335, 
2392, 2827 and 2846 adherent cells at the end of 15 min, 30 min, 45 min, 1 h, 1 
h30 min and 2 h respectively.  
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Figure 3.1 Components of the rocking adhesion system: (a) Endothelial cells 
are cultured in confocal microscope compatible dishes. (b) Cancer cells are 
labelled with PTS and added to the endothelial cells. (c) The cells are co 
incubated on a rocking platform with constant rocking. 
 
Figure 3.2.Schematic representation of experimental design of rocking adhesion 
assay: Each assay consisted of 2 ibidi dishes for the addition of MCF 7 cells 
and 2 for the addition of ZR 75 1 cells. The assay was repeated 3 times 
(a) Endothelial cells are grown in 
confocal microscope compatible 
dishes. 
(b) Cancer cells grown in flasks are laid on the 
endothelial cells. 
(c) The dishes are then rocked on a rocking platform to simulate blood flow. 
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Figure 3.3. Photomicrograph showing monolayer of HUVECs after subjecting the 
monolayers to rocking assay. The monolayer is intact with no cell loss or detachment. 
Imaging carried out with Zeiss confocal microscope, using 458 nm laser, LP 475 filter and 
25x objective. 
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Figure 3.4. Photomicrograph of MCF 7 cells with mapping of surface HPA 
binding glycans using HPA TRITC: Abundant staining with HPA TRITC on 
the surface of MCF 7 cells demonstrates that MCF 7 cells synthesize high level 
of HPA binding glycans. Photomicrograph captured using Zeiss confocal 
microscope 543 nm laser, LP 560 filter and 63x objective. 
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Figure 3.5: Results of the time series experiments for MCF 7: Showing minimal 
adhesion at 5 minutes and gradual increase in adhesion from 30 minutes to 1 
hour 30 minutes. Imaging carried out with Zeiss confocal microscope, using 
458 nm laser, LP 475 filter and 10x objective 
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Figure 3.6: Results of the time series experiments for ZR 75 1: Showing 
minimal adhesion at 5 minutes and gradual increase in adhesion from 30 
minutes to 1 hour 3 0 minutes. Imaging carried out with Zeiss confocal 
microscope, using 458 nm laser, LP 475 filter and 10x objective 
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Figure 3.7. Graphical representation of the number of adherent MCF 7 and ZR 
75 1 cells with various periods of rocking: The number of adherent cancer cells 
is minimal up to 15 minutes of rocking. From then on, there is a steady increase 
in the number of adherent cancer cells with rocking till the time period of 90 
minutes. After this period, there is no further increase in the number of adherent 
cancer cells with duration of rocking. 
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Table 3.1. Adhesion of MCF 7 cells to a monolayer of HUVECs over 
various time Points 
 
 
 
 
Table 3.2. Adhesion of ZR 75 1cells to a monolayer of HUVECs over 
various time Points 
 
 
Time points 5 min 15 min 30 min 45 min 1 hour 1.5 h 2 h 
Total  440 878 2524 2556 2937 3689 3706 
Mean (n=90) 5 10 28 28 33 41 41 
Standard 
deviation 
4.60 6.47 17.22 12.62 16.14 27.95 17.72 
SEM 0.48 0.68 1.82 1.33 1.70 2.95 1.87 
Time points 5 min 15 min 30 min 45 min 1 hour 1.5 h  2 h 
Total  479 838 1921 2325 2392 2827 2846 
Mean (n=90) 5 9 21 26 27 31 32 
Standard 
deviation 
4.24 8.85 17.19 10.85 10.19 16.33 9.94 
SEM 0.45 0.93 1.81 1.14 1.07 1.72 1.05 
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3.4. Summary of main findings 
From the experiments described in this chapter, it can be concluded that  
 Rocking adhesion assay system is a useful and reliable technique for the 
live cell imaging of adhesive interactions between cancer cells and 
endothelial cells. 
 Adhesive interactions between the cancer cells begins at an early time 
point between 5 min -15 min of rocking and then steadily increases, 
plateauing after 1h 30 min. Beyond 1 h30 min of rocking, there is no 
increase in the number of adherent cancer cells. Moreover, continued 
rocking then results in the detachment of the endothelial cells from the 
culture surface. Hence 1h30 minute was used as the duration of rocking 
for all subsequent experiments. 
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4.1. Introduction  
Metastasis, the process by which cancers spread from the primary organ of their 
origin to various target organs in the body is the main cause of cancer related 
deaths. Metastasis is a complex, multistep process brought about by the 
interplay of a variety of diverse and complex factors. Of particular relevance is 
the abnormal cellular glycosylation of cell surface glycoproteins in cancers. A 
wide array of aberrant glycosylation changes have been described as a 
prominent feature of  several cancers (for a detailed review, please refer to 
(Brooks et al., 2008a) and to Chapter 1 sections 1.7. Many of these abnormal 
glycosylation changes are associated with increased aggressiveness and 
metastatic capability of cancers. One such aberrant glycosylation change 
consisting of exposure of terminal and sub-terminal GalNAc residues in breast 
cancer that is recognised specifically by the lectin HPA is the focus of this 
research project.    
The fascinating background research pertaining to HPA binding glycans, their 
link to aggressiveness and metastatic capability in breast cancers and early 
studies to investigate the role of HPA binding glycans in metastatic cascade has 
been described in detail in chapter 1 (sections 1.8.1-1.8.4) and  has led to and is 
being continued through the work described in this thesis. To summarise, 
exposure of HPA binding glycans in breast cancer specimens  was shown to be 
associated with shorter disease free interval and poor prognosis in patients for 
the first time by Leathem and Brooks in 1987 (Leathem and Brooks, 1987). 
Further research by the same group also showed that the presence of HPA 
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binding glycans in primary breast cancer also correlated with the presence of 
lymph node metastases and was a significant, independent prognostic indicator 
in breast cancer (Brooks and Leathem, 1991, Brooks et al., 1993). These early 
findings were further substantiated by various other researchers both for breast 
cancer [for example (Fenlon et al., 1987, Fukutomi et al., 1989)] and for several 
other cancers [for example Schumacher and Adam for colon cancer 
(Schumacher and Adam, 1997). For a detailed review please see, Chapter 1 
section 1.8. The reported association between exposure of HPA binding glycans 
and metastasis led to further research to evaluate the role of HPA binding 
glycans in the various steps of the metastatic cascade in breast cancers, the first 
attempt being a matrigel invasion assay to ascertain the role of HPA binding 
glycans in the adhesion to and invasion through basement membrane. This 
study failed to find evidence that HPA binding glycans played a role in the 
adhesion of breast cancer cells to basement membrane and their subsequent 
invasion through the basement membrane (Brooks and Hall, 2002). A further, 
very limited pilot study by Valentiner et al investigated the role of HPA binding 
glycans in the adhesion of breast cancer cells to endothelial cells during the 
adhesion and transendothelial migration step of the metastatic cascade. Results 
from this study suggested that HPA binding glycans could be  involved in the 
adhesion of breast cancer cells to vascular endothelium during the adhesion and 
transendothelial migration step of the metastatic cascade (Valentiner et al., 
2005). This chapter describes further research leading on from this pilot study 
and the study by Dr. Lomax- Browne (described in Chapter 1, section 1.8.5.) 
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The experiments described in this chapter utilise three breast cancer epithelial 
cell lines of progressively diminishing aggressiveness and HPA binding 
profiles; namely MCF 7, ZR 75 1 and BT474 in a rocking adhesion assay 
system (whose optimisation is described in chapter 3) to investigate whether 
HPA binding glycans are involved in the adhesion of breast cancer cells to 
endothelial cell monolayer. The evidence corroborating the 3 cell lines used 
here as representative of clinical breast cancer specimens and hence validating 
their use in the rocking adhesion assay system have been described in chapter 1, 
section 1.8.5. The rationale behind using the semistatic assay system instead of 
the flow assay systems and the static assay system is given in chapter 3.  
For the rocking adhesion assays described in this chapter, the lectin HPA was 
utilised as the competitive inhibitor to block the HPA binding glycans on the 
surface of the breast cancer cell lines. The alternative agents for this purpose are 
the monosaccharide GalNAc or GalNAc linked to human serum albumin 
(GalNAc-HSA). In optimisation experiments of the rocking assay performed by 
Dr. Osborne, one of the previous PhD students in our group, GalNAc, when 
used as a competitive inhibitor was found to have an adverse effect on the 
endothelial cells and was found to cause their detachment from the tissue 
culture surface. GalNAc-HSA, even though it did not have any adverse effect 
on the endothelial monolayer was found to be too expensive. Hence, HPA was 
chosen as the competitive inhibitor of choice as it caused no adverse effect on 
the endothelial mono layer and was a cost effective option (Osborne, 2004).   
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4.1.1. Rocking adhesion assay with peanut agglutinin (PNA) and 
concanavalin A (Con A) pre-incubation. 
When performing rocking adhesion assays utilizing HPA as a competitive 
inhibitor, it was vital to ensure that the any inhibition in adhesion of breast 
cancer cells to endothelial cells, if it were to be observed, was due to the HPA 
binding glycans actually being functionally involved in cancer cell-endothelial 
cell adhesion and not an inhibitory effect due to a steric effect of the bulky HPA 
molecule physically interfering with other cell-cell interactions. As a control set 
of experiments, and in order to rule this out, rocking adhesion assays were also 
repeated with two other lectins, peanut agglutinin (PNA) and Concanavalin A 
(Con A) which, like HPA,  are reported to preferentially bind abnormal glycans 
in breast cancer, but to glycans distinct from the GalNAc-glycans recognized 
by HPA and of interest in this thesis. Peanut agglutinin is a tetrameric protein 
extracted from peanut (Arachis hypogaea) and exhibits preferential binding 
specificity to galactosyl(β1-3)N-acetyl galactosamine (Gal(β1-3)GalNAc), D-
galactose and T antigen, Gal(β1→3) GalNAc-Ser/Thr (Lotan et al., 1975, 
Banerjee et al., 1994).  
PNA has been shown to bind normal breast epithelial cells and epithelial cells 
in breast cancers, particularly in well differentiated adenocarcinomas (Newman 
et al., 1979). PNA is also believed to be a marker of tumour progression and 
differentiation with a sequential loss of PNA binding being demonstrated 
during progression from normal mammary cells to pre-neoplastic cells to 
mammary carcinomas.  In addition to this, an inverse relationship has also been 
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found between tumorigenicity and PNA binding (Rak et al., 1992).  In a study 
comparing PNA binding profiles of primary adenocarcinomas of breast, 
stomach and colon with their respective lymph node metastatic deposits, PNA 
binding was present in less than 5% of the primary tumours. Interestingly 
however, more than 75% of the cells in the metastatic deposits derived from 
these primary tumours showed positive binding to PNA.  It was therefore 
deduced that a PNA binding, abnormal glycosylation change has facilitated the 
progression from primary tumour to metastasis and hence, PNA binding was 
proposed as a marker of metastatic potential in adenocarcinomas including 
breast carcinomas (Kahn and Baumal, 1985). Of particular relevance to this 
thesis, in studies involving breast cancer epithelial cell lines, PNA has been 
shown to bind the highly metastatic MCF 7 cell lines and in a way that is 
proportional to the binding with HPA (Schumacher et al., 1995) and hence 
PNA has been used as one of the test lectins in the experiments described 
below. 
Concanavalin A (Con A) is a lectin derived from the jack bean (Canavalia 
ensiformis) and specifically binds the α- mannose and glucose residues and the 
trimannose core of complex glycoproteins (Bhattacharyya and Brewer, 1988, 
Naismith and Field, 1996). Haemadsorption studies utilising Con A coated 
erythrocytes with breast cancer cells have shown that Con A demonstrates 
strong reactivity to malignant breast epithelial cells. In contrast, no reactivity is 
observed in normal breast epithelial cells. This reactivity to malignant epithelial 
cells is seen both in cells derived from solid breast tumours as well as 
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malignant breast cancer cell lines including MCF 7 (Voyles et al., 1978). 
Furthermore, in a prospective, double blinded study on breast cancer specimens 
of patients operated for breast cancer, Con A reactivity was associated with 
early recurrence of tumours. In addition to this, Con A, like HPA was found to 
be an independent prognostic factor in breast cancer (Furmanski et al., 1981).  
This finding along with the fact that Con A binds to malignant breast cancer 
cell lines like MCF 7, one of the principal cell lines used in all the experiments 
described in this thesis (Voyles et al., 1978, Schumacher et al., 1995) prompted 
the use of Con A in the experiments described below. 
4.2. Materials and Methods 
4.2.1. Rocking adhesion assay with HPA inhibition 
The rocking adhesion assay optimised in the experiments described in chapter 3 
was employed in these investigations. 
1. Confluent monolayers of HUVEC cells were cultured on ibidi dishes,  
as described in section 3.2.1 steps 1-3.  
2. Cancer cells in were pre incubated with 10mg/ml solution of HPTS in 
tissue culture media overnight as described in chapter 3 section 3.2.2 
3. On the day of assay, the cancer cells were washed with 5 changes of 
fresh, warmed PBS. 
4. The cells were then trypsinised and resuspended in the appropriate 
culture media to obtain a cell suspension as described in chapter 2 
section 2.2.3 
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5. The cell suspension was then split into test and control groups. The cells 
in the test group were pre incubating with 10µg/ml solution of HPA 
(Sigma Aldrich, UK) in tissue culture medium in a 37
0
c, 5% CO2 
incubator for 2 hours to achieve binding of HPA to the cells. The 
control cell suspension was similarly incubated tissue culture medium 
without the addition of HPA. 
6. At the same time, HUVEC cell monolayers were prepared for the assay 
by removing the cell culture media from the dishes and pre-incubating 
the cells with 10ng/ml solution of TNF-α in EBM-2 media 2 hours, as 
described in chapter 3 section 3.2.1 
7. At the end of two hours, the test and control cancer cell suspensions 
were removed from the incubator, centrifuged at 1200rpm for 10 
minutes and resuspended in fresh tissue culture medium. The process 
was repeated thrice to remove any non-adherent HPA from the solution. 
8. TNF-α solution from each ibidi dishes was aspirated and replaced with 
2mls of fresh EBM-2 medium.  
9. 2x105 cancer cells from the test group and control group were added to 
the respective ibidi dishes and the dishes rocked on a rocking platform 
placed in a 37
0
c, 5% CO2 incubator and rocked for 2 hours. 
10. At the end of 2 hours, rocking was stopped and the cells were washed 
with 3 changes of warmed PBS to remove any non-adherent cancer 
cells. 2mls of fresh warmed EBM-2 medium was then added to each 
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dish and the dishes were imaged with confocal microscope using a 10x 
plan-Neofluar objective and 458 nm laser. 
11. Each experimental group consisted of two test dishes (to which cancer 
cell pre-incubated with HPA were added) and two control dishes (to 
which cancer cells without HPA pre-incubation were added). 15 images 
from random fields of view were captured from each dish and the 
experiments were repeated 3 times for each cancer cell line tested. This 
gave a total number of 90 images each for the test and control groups 
per cancer cell line tested. 
12. The number of adherent cancer cells in each image was counted 
manually and total number of adherent cancer cells from all the 90 
images for both the test and the control groups was calculated.  
13. The results were then statistically analysed using Mann Whitney test. 
4.2.2. Rocking adhesion assays with PNA and Con A pre-incubation 
Rocking adhesion assays with PNA and Con A as competitive inhibitors was 
carried out as described in the section 4.2.1 described above but with the 
following modifications: 
1. Each cancer cell line was split into four experimental groups: control 
group with no lectin pre-incubation, and HPA, PNA and Con A groups - 
pre-incubated with 10µg/ml solutions of HPA, PNA and Con A (all 
from Sigma, UK) respectively. 
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2. Since no significant increase in the number of adherent cancer cells was 
found beyond 1hour 30 minutes of rocking (as described in Chapter 3), 
assays were carried out for a duration of 1 hour and 30 minutes. 
3. Each experiment consisted of 4 dishes, one each for control (no lectin), 
HPA, PNA and Con A groups. The experiments were repeated thrice 
and 20 images were captured for each dish giving a total of 60 images 
per group for each cell line tested. The number of adherent cancer cells 
in each image was manually counted to obtain the total number of 
adherent cancer cells from all the 60 images. For example, the control 
group for MCF 7 consisted of 60 images and the total number of 
adherent cancer cells for the control group was a sum of all the adherent 
cancer cells in the 60 images.  
4.3. Results: 
4.3.1. Rocking adhesion assay with HPA pre-incubation 
Sample images of the cancer cells adherent to the endothelial cell 
monolayer post rocking adhesion assay in the control group (without HPA 
inhibition) and in the test group (with HPA inhibition) for MCF 7, ZR 75 1 
and BT 474 cell lines is shown in  shown in figure 4.1.  
For rocking adhesion assays with MCF 7 cells, in the control group (without 
HPA pre incubation), the total number of adherent cancer cells was 3706 
(mean-41) .There was a significant reduction in the number of adherent 
cancer cells in the test group (with HPA), that was easily noticeable by eye, 
as shown in Figures 4.1 a (control group) and b (test group), with total 
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number of adherent cancer cells being 1868 (mean-21). This difference was 
statistically significant (p<0.00001). The results are summarised in the 
Table 1 and represented graphically in Figure 4.2.  
Similar results were also obtained for rocking adhesion assays with ZR 75 1 
cells. The total number of adherent cancer cells for ZR 75 1 was 2846 for 
the control group (without HPA) (mean-32) and 1800 for the test group 
(with HPA) (mean-20). The difference in the adhesion was statistically 
significant (p<0.0001). The sample images for the control and test groups 
for rocking adhesion assays with ZR 75 1 cells is shown in Figure 4.1 c and 
d, summarized in Table 2 and represented graphically in Figure 4.3.  
The total number of adherent cancer cells for adhesion assays with BT474 
cells in the control group was 2058 (mean 23). The total number of adherent 
cancer cells in the test group for BT 474 cells was 1971 (mean 22). The 
difference in the number of adherent cancer cells was not statistically 
significant (p>0.2587). The sample images for rocking adhesion assays with 
BT 474 cells is shown in the Figure 4.1 e and f for the control and test 
groups respectively. The results of the assay are summarized in Table 3 and 
represented graphically in Figure 4.3 
4.3.2. Results of rocking adhesion assay with HPA, PNA and Con A pre 
incubation 
The results for the rocking adhesion assay with MCF 7 cells is shown in 
Table 4 and represented graphically in the 4.4. The total number of 
adherent cancer cells in the control group was 3019 (mean 50). The number 
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of adherent cancer cells with HPA, PNA and Con A inhibitions were 1610 
(mean 27), 2858 (mean 48) and 2893 (mean 48) cells respectively. The 
inhibition in adhesion with HPA pre incubation was statistically significant 
(p < 0.0001). The results are consistent with the results of the rocking 
adhesion assay described in 4.3.1. There was no significant inhibition in 
adhesion with the other test lectins with p value for PNA group being 
0.1681 and for Con A being 0.3805.  
The rocking adhesion assay results with ZR 75 1 cells is shown in the 
Table 5 and represented graphically in the Figure 4.5.  The total number of 
adherent cancer cells in the control group was 1380 (mean 23). The number 
of adherent cancer cells with HPA, PNA and Con A pre incubation were 
763 (mean 13), 1348 (mean 22) and 1418 (mean 24) respectively. The total 
number of adherent ZR 75 1cancer cells in the control group (without 
lectin) was fewer than in the analogous control group (without lectin) for 
MCF 7 cells.  There was significant inhibition in the adhesion with HPA 
pre incubation of both MCF7 and ZR 75 1 cancer cells. Both these findings 
were consistent with the results of the rocking adhesion assay results 
described in section 4.3.1. There was no statistically significant inhibition 
of adhesion in the presence of PNA (p =0.1110) The number of adherent 
cancer cells with Con A pre incubation was greater than in the control (no 
lectin) group but this difference did not reach statistical significance (p = 
0.6936).  
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The results of rocking assay with BT 474 are shown in Table 6 and 
represented graphically in the Figure 4.6. There were 1343 cancer cells in 
the control group (mean 22). There were 1281 (mean 21), 1325 (mean 22) 
and 1323 (mean 22) cells adherent with HPA, PNA and Con A pre 
incubation respectively. None of the results were statistically significant 
with p value for HPA group being 0.7447, for PNA group being 0.9101 
and for Con A group being 0.7328. 
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Figure 4.1.Sample images from rocking adhesion  assays with and without 
blocking by HPA in MCF 7, ZR 75 1 and BT 474 cell lines: The cancer cells 
appear green and endothelial cells appear as  grey background. Figures a and b 
show adhesion in control and test groups respectively for MCF 7ells, figures c 
and d show adhesion in control and test groups respectively for ZR 75 1 cells 
and Figures e and f show results for control and test groups for BT 474 cells 
respectively. Imaging carried out with Zeiss confocal microscope, using 458 
nm laser, LP 475 filter and 10x objective 
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Table 1.Adhesion of MCF 7 cells to HUVECs monolayer in the 
presence and absence of HPA. 
 
 Control group Test group 
Total number of adherent cancer 
cells 
3706 1868 
Mean 41 21 
Standard deviation 17.72 7.41 
Standard error of mean 1.87 0.78 
Two-tailed P value < 0.0001  
Significance Significant 
 
 
 
Figure.4.2. Adhesion of MCF 7 cells to HUVECs monolayer in the control and 
test groups. The control group without HPA inhibition is shown in blue and the 
test group with HPA inhibition is shown in red. Significant inhibition of 
adhesion is seen in the test group compared to the control group. 
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Table 2.Adhesion of ZR 75 1 cells to HUVECs monolayer in the 
presence and absence of HPA inhibition 
 
 Control group Test group 
Total number of adherent cancer 
cells 
2846 1800 
Mean 32 20 
Standard deviation 9.94 6.12 
Standard error of mean 1.05 0.64 
Two-tailed P value < 0.0001  
Significance Significant 
 
 
 
Figure.4.3. Adhesion of ZR 75 1 cells to HUVECs monolayer in the control and 
test groups. The control group without HPA pre incubation is shown in green 
and the test group with HPA inhibition is shown in yellow. Significant 
inhibition of adhesion is seen in the test group compared to the control group 
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Table 3.Adhesion of BT 474 cells to HUVECs monolayer in the 
presence and absence of HPA. 
 Control group Test group 
Total number of adherent cancer 
cells 
2058 1971 
Mean 23 22 
Standard deviation 10.05 10.71 
Standard error of mean 1.06 1.13 
p  value > 0.2587 
Significance Not significant 
 
 
 
Figure.4.3. Adhesion of BT 474 cells to HUVECs monolayer in the control and 
test groups. The control group without HPA pre incubation is shown in green 
and the test group with HPA pre incubation is shown in blue. Minimal 
inhibition of adhesion is seen in the test group compared to the control group 
and this is not statistically significant 
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Table 4.Adhesion of MCF 7 cells to HUVECs monolayer with 
HPA, PNA and Con A inhibition 
 Control HPA PNA Con A 
Total number of 
adherent cancer cells 
3019 1610 2858 2893 
Mean 50 27 48 48 
Standard deviation 15.72 9.01 20.04 20.81 
Standard error of mean 2.03 1.16 2.59 2.69 
 p value  N/A < 0.0001 = 0.1681 = 0.3805 
Significance N/A Significant Not significant 
 
 
 
Figure.4.4. Adhesion of MCF 7 cells to HUVECs monolayer with HPA, PNA 
and Con A inhibition. The control group without HPA pre incubation is shown 
in sky blue. HPA group is shown in red, PNA group in green and Con A group 
is shown in light blue. There is a statistically significant inhibition of adhesion 
with HPA pre incubation (p<0.001) but no inhibition of adhesion is seen with 
the other two lectins. 
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Table 5.Adhesion of ZR 75 1 cells to HUVECs monolayer with 
HPA, PNA and Con A inhibition 
 Control HPA PNA Con A 
Total number of 
adherent cancer cells 
1380 763 1348 1418 
Mean 23 13 22 24 
Standard deviation 8.04 7.44 15.56 12.12 
Standard error of mean 1.04 0.96 2.01 1.56 
 p value  N/A < 0.0001 = 0.1110 = 0.6936 
Significance N/A Significant Not significant 
 
 
 
Figure.4.5. Adhesion of ZR 75 1 cells to HUVECs monolayer with HPA, PNA 
and Con A inhibition. The control group without HPA pre incubation is shown 
in sky blue. HPA group is shown in red, PNA group in green and Con A group 
is shown in light blue. There is a statistically significant inhibition of adhesion 
with HPA pre incubation (p<0.001) but no inhibition of adhesion is seen with 
the other two lectins. 
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Table 6.Adhesion of BT 474 cells to HUVECs monolayer with 
HPA, PNA and Con A pre incubation 
 Control HPA PNA Con A 
Total number of 
adherent cancer cells 
1343 1281 1325 1323 
Mean 22 21 22 22 
Standard deviation 11.28 9.23 10.12 12.14 
Standard error of mean 1.46 1.19 1.31 1.57 
p value  N/A = 0.7447 = 0.9101 = 0.7328 
Significance  N/A Not significant 
 
 
 
Figure.4.6. Adhesion of BT 474 cells to HUVECs monolayer with HPA, PNA 
and Con A pre incubation. The control group without HPA pre incubation is 
shown in sky blue. HPA group is shown in red, PNA group in green and Con A 
group is shown in light blue. There no inhibition in adhesion with any of the 3 
lectins.  
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4.4. Summary of main findings 
 
 The results from the experiments described in this chapter are consistent 
with HPA binding glycans playing a functional role in the adhesion of 
cancer cells to endothelium. The number of cells adherent to the 
endothelial monolayers was consistent with both the derivation of the 
cells and their HPA-binding characteristics. Thus, those derived from 
metastatic sources, MCF7 and ZR 75, exhibited greater adhesiveness to 
endothelial cells than those derived from non-metastatic primary tumor, 
BT 474. The MCF 7 cell line, labels most strongly with HPA, also 
exhibits the maximum number of adherent cancer cells. This was 
followed by ZR 75 17 which exhibit slightly less HPA binding, and 
finally by BT474 which is very weakly HPA binding.  
 There was a significant decrease in the adhesion of cancer cells to the 
endothelial cell monolayer when HPA binding glycans were blocked by 
pre-incubation of the cells with the lectin in the MCF 7 and ZR 75 1 cell 
lines. No statistically significant inhibition in adhesion was found in BT 
474 cells. Thus, physically blocking exposure of HPA binding glycans 
has an inhibitory effect on the binding of the metastatic breast cancer 
cells to the endothelial cells, consistent with the HPA-binding glycans 
being functionally implicated in this cell-cell adhesive interaction 
during adhesion and transendothelial step of metastatic cascade. 
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 Significant inhibition of adhesion was demonstrated with HPA pre 
incubation with HPA in the two metastatic cancer cell lines tested. 
However, no inhibition in adhesion was demonstrated with BT 474 cell 
line. There was also no inhibition demonstrated in all the three cell lines 
with PNA and ConA inhibition. These results are therefore consistent 
with HPA binding glycans playing a functional and specific role in  the 
adhesion of breast cancer cells to endothelial cells during adhesion and 
transendothelial migration. 
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5.1. Introduction 
Adhesion of metastatic cancer cells in the circulation to the vascular 
endothelium and their subsequent transmigration across the endothelial layer 
has been shown to be a crucial and limiting step in the metastatic cascade (Tarin 
et al., 1984). Mechanisms utilised by metastasising cancer cells during adhesion 
and transendothelial migration are thought to be similar to leucocyte adhesion 
and transendothelial migration during an inflammatory response as described in 
section 1.3 . Unlike adhesion and transendothelial migration in leucocytes, 
which has been extensively researched at the molecular level and is well 
reviewed [e.g. (Barreiro and Sanchez-Madrid, 2009, Carlos and Harlan, 1994)] 
the analogous process in cancer cells is still poorly understood.  
The main steps of leucocyte adhesion and transendothelial migration during 
inflammation can be briefly summarised as below (for an in depth description 
of the same, please refer to sections 1.4.)  The first step involves the recruitment 
of leucocytes from the blood stream. Leucocytes initially tether and then roll 
along the activated vascular endothelium. The process of tethering and rolling 
is mediated through selectin-carbohydrate mediated interactions (Crockett-
Torabi, 1998, Symon and Wardlaw, 1996). A comprehensive description of 
structure and function of selectins, selectin ligands and their function is given in 
section 1.3.11 and section 1.4.1.  
Selectin mediated rolling results in activation of integrins and causes firm 
adhesion of the leucocytes to the endothelial surface (Gahmberg et al., 1997).  
Integrins, their ligands and their combined role in firm adhesion of leucocytes is 
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described in Chapter 1 sections 1.3.12-13 and 1.4.2-1.4.3. Adherent leucocytes 
then crawl along the endothelial layer until they reach the intercellular 
junctions. The endothelial cells then retract and leucocytes use diapedesis to 
migrate out of the blood vessel. This mode of transmigration in between the 
retracted endothelial cells is referred to as para cellular migration. In addition to 
para cellular migration, some leucocytes pass directly through the endothelial 
cells and this process is called as trans cellular migration. Paracellular and 
transcellular migration have been shown to be mediated by several molecules, 
including ICAMs, VCAMs, PECAMs and JAMS (Nourshargh et al., 2006, 
Rahman and Fazal, 2009, Wittchen, 2009).  
There are several similarities between leucocyte adhesion and transendothelial 
migration and those of cancer cells. There are also some important differences. 
The similarities and differences between the two processes has been well 
reviewed by Strell and Entschladen (Strell and Entschladen, 2008) and can be 
summarised as follows. 
Like leucocytes, selectins appear to be the main mediators of rolling in cancer 
cells (Hanley et al., 2006). The role of selectins, however, is not limited to 
rolling alone and selectins have been shown to mediate cancer cell diapedesis 
across endothelial layer (Tremblay et al., 2008). In addition to selectins, other 
mediators have been implicated in mediating cancer cell rolling. For example, 
N-cadherins were found to mediated MDA-MB-468 cells on pulmonary 
vascular endothelium (Strell et al., 2007). 
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Like leucocytes, firm adhesion in cancer cells has been shown to be mediated 
by integrins [for e.g.(Garofalo et al., 1995)]. Other mediators have also been 
implicated in firm adhesion of cancer cells to endothelial layer. Galectin and 
Thomsen-Freidenreich antigen (TF or T antigen) mediated interactions have 
been shown to result in  adhesion of breast and prostate cancer cell adhesion to 
endothelium (Glinsky et al., 2001). Like selectins, the role of integrins in cancer 
cell adhesion is not limited to firm adhesion alone. αvβ3 integrins have been 
implicated in mediating transmigration of melanoma cells across endothelium 
(Voura et al., 2001). 
Unlike transendothelial migration of leucocytes, which doesn’t permanently 
damage vascular endothelial layer integrity (Huang et al., 1988), cancer cell 
transmigration has been shown to result in irreversible damage to the integrity 
of the endothelial monolayer (Heyder et al., 2002). 
Hence, the main aim of the experiments carried out in this chapter was to study 
the post adhesive behaviour of the cancer cells, utilising the approaches of live 
cell imaging and high resolution imaging with scanning electron microscopy.  
For live cell imaging of post adhesive behaviour of cancer cells, an innovative 
smartslide system called the Wafergen smartslide system (Wafergen 
Biosystems, UK) was incorporated in to the rocking adhesion assay system. 
The Wafergen smartslide system consists of a 6 well, confocal microscope 
compatible well plate with a lid. The base and the lid possess independent 
temperature controls and the base, in addition, also possesses microinjection 
ports on the side for gas flow. The smartslide system can be directly mounted 
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onto the confocal microscope and when connected to its base unit for 
temperature control and a gas supply, functions as a micro incubator system and 
allows long term imaging of live cells. The system in illustrated in figure 5.1 
 
5.2. Materials and methods 
5.2.1. 24 hour live cell imaging with Wafergen smartslide system 
1. Monolayer cultures of HUVEC cells were established in one well of a 6 
well smartslide (for details of endothelial cell culture please refer to 
Chapter 2). 
2. MCF 7 cells labelled with HPTS were placed on the endothelial cell 
monolayer and rocking adhesion assay was carried out as described in 
Chapter, section 3.2.2. 
3. Post rocking, the endothelial cells were washed with 3 changes of PBS 
and 5mls of fresh warmed EBM 2 media was added to the cells. The 
smartslide was placed on its compatible holder on the confocal 
microscope. The slide was then connected to the base unit of the 
smartslide system to maintain the temperature of the base plate at 37
0
c. 
The temperature of the lid was set at 38
0
c to prevent condensation 
during prolonged imaging. Through the micro injection port at the side, 
5% O2 air mixture was continuously passed in to the micro incubating 
system.  
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4. Optimum field of view were selected with sufficient number of adherent 
cancer cells without overcrowding and imaging was carried (458 laser, 
10x plan-Neofluar objective).  
5. The microscope was set to capture 1 image every 5 minutes and the 
imaging was carried out for a period of 24 hours.  
6. After the imaging, the images were collated in to a movie by utilising 
LSM image browser and Microsoft movie making software.  
5.2.2. Scanning electron Microscopy (SEM) 
1. The endothelial cells were cultured on plastic coverslips placed at the 
bottom of 24 well plates. 
2. The rocking adhesion assay was carried out using MCF 7 cells without 
HPTS pre labeling as described in section 3.2.2 
3. Post adhesion, the 24 well plates were incubated in a 370c, 5% CO2 
incubator. 
4. The plates were removed from the incubator at the end of 5 1 hour, 2 
hours, 6 hours, 12 hours and 24 hours post adhesion and processed for 
imaging for SEM as described below 
5. The cells were fixed with 2% glutaraldehyde  (TAAB, U.K) + 2% 
paraformaldehyde (Agar Scientific) in 0.1M sodium cacodylate (Agar 
Scientific)  at pH 7.4 for 1 hour 
6. The cells were then washed three times and soaked with 1% osmium 
tetroxide (Agar Scientific) for 1 hour.  
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7. The cells were washed 3 times and then dehydrated for 20 minutes each 
with 20%, 30% 50%, 70%, 90% and 100% ethanol alcohol solutions.  
8. Further dehydration was carried out by placing 100% ethanol dried over 
anhydrous sodium sulphate on the cell layer till critical point drying was 
carried out. 
9. At the end of dehydration process, the coverslips were mounted on stubs 
with adhesive and critical point dried using a Samidry critical point 
dryer. 
10. The cells were sputter coated with gold using a conductive metallic 
sputter coater (Agar auto sputter coater) and imaged using  Hitachi 
3400N scanning electron microscope.  
11. The entire process of fixation and imaging with scanning electron 
microscopy was performed with the help and guidance of Mr. Barry 
Martin, Laboratory Manager. 
5.3. Results 
The components of the Wafergen smartslide system are shown in Figure 
5.1. The results of the 24 imaging series utilising Wafergen smartslide 
system are shown in the attached movies 1 and 2 and still images are given 
in Figure 5.2. The adherent cancer cells are in constant crawling motion in 
the time period between 1 hour to 6 hours. From 6 hours post adhesion, the 
endothelial cells begin to retract and the cancer cells settle in the gaps 
between these endothelial cells. From 10-12 hour onwards, the cancer cells 
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settled in the gap between endothelial cells begin to divide to form colonies 
of cancer cells. 
Similar results are also seen when high resolution imaging is carried out 
using scanning electron microscopy. Figure 5.3 shows adherent cancer cells 
1 hour post adhesion. Cancer cells 2 hour post adhesion are shown in Figure 
5.4. The cancer cells put out finger-like projections which might aid in 
crawling. Figures 5.5 shows retracted endothelial cells and cancer cells 
settling in the gap between the endothelial cell monolayer 6 hours post 
adhesion. Figures 5.6 shows cancer cells settled in the gap between 
endothelial cells dividing. Figure 5.7 shows trans cellular migration of 
cancer cells through endothelial cells. 
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Figure.5.1. The Wafergen smartslide system: The system consists of a 
smartslide which has in built temperature control and inlet for CO2. The 
smartslide is also compatible with confocal microscopy thereby allowing 
continuous imaging of live cells 
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Figure.5.2. Static images of adherent MCF 7 cells at different time points post 
adhesion  Figures a and b. In the initial period, the cancer cells adhere on the 
endothelial layer and flatten out. Figures c and d. 12-24 hours post adhesion the 
endothelial cells form a clear zone around the cancer cells  and the cancer cells 
settle in this area  of clearance and divide. Imaging carried out with Zeiss 
confocal microscope, using 458 nm laser, LP 475 filter and 25x objective 
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Figure.5.3. 1 hour post adhesion. The cancer cells are found adherent to 
endothelial monolayer and show a rounded appearance. Magnification x1.6k 
with 75
 
degree tilt 
 
Figure 5.4. 2 hours post adhesion: Cancer cells extending processes which 
appear to be helping with crawling along the endothelial monolayer. 
Magnification x3.00k with 75 degree tilt 
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Figure 5.5. 6 hours post adhesion. The cancer cells are shown to be migrating in 
the gap between endothelial cells. Magnification x2.30k 
 
 
 
 
 
 
 
 
 
Figure 5.6. 12 hours post adhesion. The cancer cells are shown to be migrating 
in the gap between endothelial cells. The endothelial cells are present in a 
confluent monolayer and a clear zone is present just around the cancer cell. 
Magnification x1.80K 
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Figure 5.7. 12 hours post adhesion: Cancer cells are shown in cell division. 
Magnification x1.70k 
 
 
Figure 5.8. Transcellular migration: Cancer cell migrating through endothelial 
cell. Magnification x1.80k 
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Figure 5.9.Transcellular migration A higher resolution image showing 
transcellular migration. Magnification x4.50k 
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5.4. Summary of main findings.  
From experiments described in the above sections, it can be visualised that 
post adhesion, cancer cells crawl along the endothelial cell monolayers. The 
endothelial cells retract to let the cancer cells pass through the endothelial 
monolayer and the cancer cells divide to form colonies of cancer cells. 
During transmigration, the majority of the cancer cells utilise para cellular 
migration even though, transcellular migration was also observed. This 
behaviour of cancer cells appears to be similar to the behaviour of 
leucocytes during inflammation described in section 1.4.4 . However, 
further quantitative data with confocal microscopy and scanning electron 
microscopy is needed to ascertain this. 
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6.1: Introduction 
As described in chapter 1, section 1.2, cancer metastasis, the dissemination of 
cancers from the primary organ of their origin to other organs in the body is the 
most important cause of cancer related deaths. Metastasis is brought about by a 
series of highly co-ordinated and sequential set of events and is often termed a 
cascade. The steps of the metastatic cascade include angiogenesis, detachment 
of the tumour cells from the main tumour mass, intravasation, dissemination of 
the cancer cells via the blood stream to various organs, adhesion and trans 
endothelial migration in the target organs and finally the formation of 
metastatic tumour foci in the target organs (Chambers et al., 2002, Brooks et 
al., 2010). It has been long recognised that adhesion and transendothelial 
migration step of the metastatic cascade is one of the limiting and key steps of 
the metastatic cascade (Tarin et al., 1984). Hence this step of the metastatic 
cascade was the focus of the experiments described in this thesis and was 
studied in a model of breast cancer metastasis.  
Abnormal glycosylation of proteins on the surface of cancer cells is reported to 
be a salient feature of several cancers, as described in section 1.7.  and such 
changes have been linked to enhanced metastatic capability and hence poorer 
patient prognosis in these cancers (Brooks et al., 2008a). Among the abnormal 
glycosylation changes associated with cancers, glycans with terminal and sub 
terminal GalNAc residues specifically recognised by the lectin HPA are of 
particular interest. Described as a marker of poor prognosis for the first time in 
breast cancers by Leathem and Brooks in 1987 (Leathem and Brooks, 1987), 
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the presence of HPA binding glycans were subsequently found to be associated 
with metastatic capability and poor prognosis in several other cancers including 
cancers of oesophagus, stomach, colon and lung  (Fukutomi et al., 1989, Alam 
et al., 1990, Kakeji et al., 1991, Noguchi et al., 1993, Thomas et al., 1993, 
Yoshida et al., 1993, Schumacher and Adam, 1997, Chen et al., 2007, Fenlon et 
al., 1987). In addition to this, in breast cancers, a vital and significant link was 
found between the presence of HPA binding glycans on cells of the primary 
tumour and lymph node metastasis – thus, with a physical manifestation of 
metastatic competence (Brooks and Leathem, 1991, Brooks et al., 1993). As a 
result of this strong association between HPA binding glycans and metastasis, 
investigations to link HPA binding glycans to a specific step of the metastatic 
cascade were embarked upon. The first in the series of studies searching for a 
link between HPA binding glycans and a specific step of the metastatic cascade 
was an investigation by Brooks and Hall (Brooks and Hall, 2002). This study 
investigated whether HPA binding glycans were involved cancer cell adhesion 
to, and invasion of, basement membrane and was carried out by using a 
matrigel invasion assay. This study found no link between HPA binding 
glycans and adhesion of cancer cells to basement membrane. 
A very limited pilot study was then undertaken to investigate the role of HPA 
binding glycans in the adhesion of cancer cells to vascular endothelium. In this 
study, HPA binding glycan inhibition was found to significantly reduce the 
adhesion of breast cancer cells to the endothelial cell layer thereby providing 
tantalising evidence that HPA binding glycans present on cancer cell surface 
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might contribute to adhesion of the cancer cells to vascular endothelial cells 
(Valentiner et al., 2005). Furthering this early work, the role of HPA binding 
glycans in endothelial adhesion and transendothelial migration was chosen as 
the main focus for further investigations through experiments described in this 
thesis.  
To bring about the adhesion of the cancer cells to endothelial monolayers, a 
semi static rocking adhesion assay system previously developed in house was 
employed. However, since it was not previously optimised for live cell imaging 
which formed an essential component of several experiments in this project, the 
assay system needed to be further developed and optimised to facilitate live cell 
imaging.  
The key aims of the project, as already stated in chapter 1, section 1.9, were 
therefore 
 To develop and optimise rocking adhesion assay system to incorporate 
and enable live cell imaging 
 To investigate whether HPA binding glycans play a functional role in 
the adhesion of breast cancer cells to endothelial cells  
 To study the post adhesive behaviour of cancer cells with the aid of 
confocal laser microscopy and scanning electron microscopy 
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6.2. Summary of the key findings: 
6.2.1 Optimization of rocking adhesion assay system for live cell imaging 
(described in Chapter 3):  
 Trial rocking adhesion assays with HUVEC cell monolayers cultured on 
confocal microscope compatible dishes, on imaging, displayed viable 
cells at the end of rocking assays with no apparent loss of integrity of 
the endothelial monolayer or detachment of the cells from the culture 
surface. This indicated that live HUVEC cells cultured on confocal 
microscope compatible dishes could withstand the shear forces 
produced during rocking adhesion assays could be incorporated in the 
assay systems. 
 The viability of the cells and integrity of the monolayers was not lost for 
the entire duration of imaging. 
 Adhesion assays with MCF 7 and ZR 75 1 cells to investigate the 
optimum time of rocking to be employed to obtain the maximum 
number of adherent cancer cells for quantitative assays showed that 
adhesion begins at early time points (5-15 min), increases progressively 
with the duration of rocking to a maximum of 1 hour 30 minutes of 
rocking and then plateaus up to a period of rocking of 2 hours. Hence all 
subsequent rocking adhesion assays were carried out with 1hour 30 
minutes – 2hours of rocking 
The rocking adhesion assay system was employed in all of the experiments 
described in this thesis to produce the adhesion of cancer cells to endothelial 
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monolayers. Traditionally,  there are two types of in vitro adhesion assays 
systems -  namely static adhesion assays, where leucocytes or cancer cells are 
placed on endothelial layer and adhesive interactions take place under static 
conditions,  and flow assays where leucocytes or cancer cells are perfused over 
the endothelial cell layers and adhesive interactions take place under conditions 
of flow. Static adhesion assays are simple to set up and easy to perform and 
require no specialist equipment. Hence they are ideal in experiments requiring 
greater throughput, for example when quantitative data is required (Butler et al., 
2009) and have been used extensively in studying adhesive interactions both in 
leucocytes [for e.g. (Bevilacqua et al., 1985, Gimbrone et al., 1984) ] and in 
cancer cells [for e.g. (Dejana et al., 1988, Heimburg et al., 2006). However, 
static adhesion assays do not provide conditions of flow which produce shear 
forces across the endothelial layer. Shear forces produced by conditions of flow 
have been shown to up-regulate vital adhesion molecules like ICAM-1 and 
hence leucocytes adhesion to endothelial cells (Nagel et al., 1994, Morigi et al., 
1995). Flow assays closely mimic physiological conditions and in addition, 
possess the advantage of providing precise control of experimental conditions 
like flow rate and shear forces across the endothelial layer (Morigi et al., 1995) 
but tend to be expensive, time consuming, technically complex and require 
specialist cell culture and microscopy equipment.  
The rocking adhesion assay system used in this project has the advantage of the 
static assay system in that it is easy to set up and allows multiple repetitions of 
experiments for quantitative analysis but provides the conditions of flow 
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required for up-regulation of adhesion molecules like the flow assays. 
However, its main disadvantage is that experimental conditions like flow rate 
and shear forces cannot be controlled and also the electrical components of the 
rocking platform tend to heat up on prolonged use which has a potential to 
change experimental conditions. 
The experiments to assess the number of adherent cancer cells in relation to the 
time described in chapter 3 section 3.2.2 of rocking showed a gradual increase 
in the number of adherent cancer cells with duration of rocking up to 1 hour 30 
minutes. In previously reported flow assay experiments to assess the expression 
of adhesion molecules in response to laminar flow, a time dependant and 
gradual increase in the expression of ICAM-1 was seen in HUVEC cell 
monolayers exposed to shear forces compared to HUVECs in static conditions. 
In addition to this, there was up-regulation of leucocyte adhesion in the cells 
subjected to laminar flow compared to those in static conditions (Morigi et al., 
1995). It is therefore likely that in the rocking adhesion assays, with continued 
rocking, there was gradual up-regulation and recruitment of adhesion molecules 
and hence produced progressive increase in the number of adherent cancer cells 
with relation to time. Saturation of all the adhesive molecules with progressive 
increase in cancer cell adhesion with time is likely to have resulted in the 
plateau reached after 1 hour 30 minutes of rocking. 
6.2.2. Rocking adhesion assays to investigate the role of HPA binding glycans 
in the adhesion of cancer cells to endothelial cell monolayer (described in 
Chapter 4): 
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 Three breast cancer cell lines: MCF 7 cells, derived from metastatic 
breast cancer and with a high surface HPA binding glycan profile, ZR 
75 1 cell line, representing intermediate aggressiveness and HPA 
binding glycan profile, and BT 474 cell line representing primary, non-
metastatic breast cancer with minimal surface HPA binding glycans as 
(described in chapter 2, section 2.1) were employed in the rocking 
adhesion assays.  
 Rocking adhesion assays using MCF 7 and ZR 75 1 cell lines with and 
without HPA inhibition showed that there was significant reduction in 
the adhesion of the cancer cells to endothelial monolayer when HPA 
binding GalNAc –glycans were masked. No difference in adhesion was 
found in the poorly HPA-binding BT474 cells with or without HPA 
inhibition.  
 The number of adherent cancer cells and hence the degree of inhibition 
of adhesion appeared to be directly proportional to the HPA binding 
glycan profile of the cancer cells, being greatest in MCF 7 cells.  
 Control experiments involving pre-inhibition with the lectins PNA and 
Con A showed no decrease in the adhesion of the cancer cells to the 
endothelial monolayer with either of these lectins.  
The cell lines utilised in the rocking adhesion assays were chosen to represent a 
spectrum of malignant disease presentation. Thus, BT 474 cell lines derived 
from primary ductal carcinoma represent non metastatic, primary breast 
carcinoma cells (Lasfargues et al., 1978),  ZR 75 1 cells derived from malignant 
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ascites secondary to ductal carcinoma of the breast (Engel et al., 1978) 
represent cells of intermediate aggressiveness and MCF 7 cells derived from 
malignant pleural effusion secondary to infiltrating ductal carcinoma of breast 
(Soule et al., 1973) represent aggressive, metastatic breast cancer cells. The 
cancer cell lines also have well established HPA binding profiles with MCF 7 
cells possessing the maximum, ZR 75 1 with intermediate and BT 474 with 
minimal surface GalNAc-glycans, and hence HPA binding profiles.  
Rocking adhesion assays with HPA inhibition showed a significant decrease in 
the adhesion of cancer cells to endothelial cells when performed using MCF 7 
and ZR 75 1 cell lines. No significant reduction in adhesion of poorly HPA-
binding BT 474 cells was seen. These are novel findings and provide evidence 
that HPA binding glycans may play a functional role in the adhesion of breast 
cancer cells to endothelial cells during metastasis. These findings are entirely 
consistent with, and further reinforce, preliminary data reported by Valentiner 
et al (Valentiner et al., 2005).  Moreover, the number of adherent cancer cells 
and the inhibition in adhesion was greatest in MCF 7 cells which possess the 
maximum amount of surface HPA binding glycans of the three cell lines and 
least in BT 474 cells.  
Adhesion assays carried out in the presence or absence of PNA and Con A 
binding  confirm that the inhibition in adhesion seen in the presence of HPA 
binding is a specific phenomenon, unlikely to be secondary to steric binding. 
This may suggest that HPA binding glycans could be recognising and 
specifically binding a putative receptor on the endothelial cell surface. Since, 
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the exact identity of HPA binding glycans on cancer cells remain incompletely 
characterised despite exhaustive research (Dwek et al., 2001, Saint-Guirons et 
al., 2007), the identification of this putative receptor might aid in the 
understanding of this complex process. 
Finally, there is a need to link the findings from the rocking adhesion assay 
with HPA inhibition described in this thesis to the broader perspective of 
adhesion and transendothelial migration step of the metastatic cascade and its 
similarity to leucocyte adhesion and transendothelial migration.  
Several new advances have been made in the study of breast cancer cell 
metastasis.  Endothelial E selectin has been shown to be involved in breast 
cancer cell transmigration through its ligand CD44v4 (Zen et al., 2008).  In 
addition to this selectin ligand Sialyl- Lewis x antigen has been shown to drive 
metastasis in ER positive breast cancers and with ER positive breast cancers 
with high expression of sialyl Lewis x correlated with metastasis (Julien et al., 
2011). However, the role played by HPA binding glycans in adhesion and 
transendothelial migration is still unclear Hence, it is impossible to define the 
exact role of HPA binding glycans in this intricate and likely to be highly 
specialised set of events without further research.  
Protein elution from HPA affinity chromatography and subsequent 
characterisation of these proteins by proteomic analysis has revealed that HPA 
binding proteins include molecules like integrin α6, integrin α5 and annexins, 
which are involved in cell adhesion and migration, filament proteins like α-
tubulin, β-tubulin, cytokeratins and actin which are involved in remodelling, 
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and HSP-70, HSP-90, HSP-96 and TNFR-1 which are involved in antiapoptotic 
pathways. While several of these molecules have been associated with cancer 
and might be subject to abnormal glycosylation and hence recognised by HPA, 
the exact mechanism of binding of these complexes to HPA is still unclear. 
Some of these molecules might bind HPA directly through the lectin-glycan 
interactions described earlier, while others might bind HPA indirectly by 
forming complexes with HPA binding glycoproteins, for example, by binding 
O-GlcNAc glycoproteins in the cytoplasm (Saint-Guirons et al., 2007). 
6.2.3. Study of the behaviour of the cancer cells post adhesion (described in 
chapter 5) 
  Study of post adhesive behaviour of cancer cells by live cell 
imaging using the Wafergen smartslide system showed that in 
the initial phases of the imaging (up to 6 hours post adhesion) 
the adherent cancer cells crawled on the endothelial monolayer. 
The endothelial cells in the vicinity of the adherent cancer cells 
then retracted forming a zone of clearance around the cancer 
cells. The individual cancer cells then flattened out in this zone 
and proceeded to divide forming a new colony of cancer cells. 
 This sequence of events follows a pattern similar that reported to 
the post adhesive behaviour of leucocytes during the 
inflammatory response as described in section 1.3 and 1.4  
 Higher resolution microscopy of the same process using 
scanning electron microscopy produced images consistent with 
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those obtained using confocal microscopy of live cells. In the 
early stages of the adhesion (1-2 hours post adhesion) cancer 
cells bearing finger-like projections were imaged. In the 
intermediate time points (6-12 hours), areas of clearance 
apparently resulting from endothelial cell retraction were seen.  
In the later stages dividing cancer cells were seen nestled in the 
areas cleared by the endothelial cells, and cancer cell 
transmigration through endothelial cells was also captured. 
 Adhesion and transendothelial migration in cancer cells is 
thought to involve mechanisms similar to leucocyte adhesion 
transendothelial migration and is therefore often termed 
‘leukocyte mimicry’ (Barthel et al., 2007, Albini, 1998).  The 
understanding of the process of adhesion and transendothelial 
migration in cancer cells is still limited, but according to 
available evidence, there are several similarities and certain, vital 
differences in comparison to leucocyte adhesion and 
transendothelial migration and these are highlighted below. 
6.2.4. Selectin mediated rolling: 
Like leucocytes, cancer cells appear to utilise selectin mediated rolling. Unlike 
leucocytes, cancer cells lack the expression of selectins and instead, express 
selectin ligands. Expression of selectin ligands has been associated with 
enhanced metastatic capability (Kannagi et al., 2004, Strell and Entschladen, 
2008), thereby indicating that they might be facilitating cancer cell adhesion to 
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endothelial cells.  For example, E selectin ligands, which are vital for E-selectin 
mediated binding to endothelial cells, have been shown to be expressed in 
metastatic prostate carcinoma cells (Dimitroff et al., 2005). In addition to 
expressing E-selectin ligands, cancer cells have also been found to possess the 
ability to induce endothelial E-selectin expression in endothelial cells. (Kannagi 
et al., 2004) and might aid E-selectin mediated adhesion of cancer cells to 
endothelium.  In colon cancer cells slow, intermediate and fast rolling have 
been found to be mediated by E-, P- and L-selectins respectively (Hanley et al., 
2006).  P selectin binding has been shown to produce integrin activation in 
colon carcinoma cells and this process is in keeping with activation of integrins 
produced by selectins in leucocyte adhesion (Reyes-Reyes et al., 2006).  
However, unlike leucocyte adhesion, where selectins alone mediate rolling, in 
cancers, selectins have been shown to mediate the diapedesis of cancer cells 
through endothelial layer (Tremblay et al., 2008).  Furthermore, mediators other 
than selectins have also been implicated in mediating rolling of cancer cells. 
For example, rolling in MDA-MB-468 breast carcinoma cell lines have been 
shown to be mediated by N- cadherin (Strell et al., 2007).  Hence, it can be 
deduced that though tumour cells appear to utilise selectin mediated rolling 
similar to leucocytes, the role of selectins in the adhesion and transendothelial 
migration in cancers might not be limited to rolling alone and might be 
involved in other aspects of adhesion and transendothelial migration. In 
addition to this, mediators other than selectins might also play a role in tumour 
cell rolling.  
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Due to the nature of rocking adhesion assay system, imaging of adhesive 
behaviour could only be performed in the later stages of cancer cell adhesion 
i.e. once firm adhesion of cancer cells to endothelial surface had occurred and 
flow adhesion assays with direct video–microscopic imaging would be required 
to image the initial events in cancer cell adhesion.  
6.2.5. Integrin mediated firm adhesion 
The function of integrins in mediating firm adhesion and in the subsequent 
crawling of leukocytes on endothelial cell monolayers is well described 
(Barreiro and Sanchez-Madrid, 2009). 
There is evidence that cancer cells might utilise other members of the integrin 
family for this process. For example, the integrin very late antigen 4 (VLA-4) 
was shown preferentially cause the binding of melanoma cells to VCAM-1 
(which is the ligand for VLA-4 on activated endothelial cells) and this caused 
significant augmentation in the formation of metastatic colonies in nude mice. 
(Garofalo et al., 1995). However, like selectins being implicated in rolling, the 
role of integrins is not restricted to firm adhesion alone in cancers. αvβ3 
integrins have been shown to mediate the transendothelial migration of 
melanoma cells by their interaction with the adhesion molecule L1 (Voura et 
al., 2001). Of particular interest to this thesis, in addition to integrins, Thomsen-
Freidenreich antigen and galectin mediated adhesion has been shown to be 
involved in the adhesion of breast and prostate cancer cells to the vascular 
endothelium (Glinsky et al., 2001).  
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The experiments described in chapter 4 indicate that HPA binding glycans may 
be involved in mediating adhesion of cancer cells to endothelial cells. However, 
the exact mechanism of adhesion is as yet unexplored  still largely unknown. It 
remains to be seen therefore, whether like T antigen, whether binding is being 
mediated by a specific adhesion molecule interacting with HPA binding 
glycans on cancer cell surface. Characterisation of the putative HPA binding 
glycan receptor on endothelial cells would shed light on this 
6.2.6. Transendothelial migration 
Leucocytes utilise two methods to transmigrate across the vascular 
endothelium- paracellular migration where in the leucocytes pass between two 
endothelial cells and trans cellular migration in which leucocytes pass through 
the endothelial cells. For an in depth description of leucocyte migration and the 
mediators of trans and para cellular migration, please refer to chapter 1 section 
1.3 and 1.4 
From the results of chapter 5, it is clear that cancer cells also appear to utilise 
similar modes of migration as leucocytes i.e. post adhesion the cancer cells 
crawl along the endothelial cell surface, the endothelial cells then retract and 
cancer cells move in to this retracted area and divide (please refer to Figures 
and Movies 1, and 2). In addition to this, in the SEM images, trans cellular 
migration was also noted.  
It is well known that after leucocyte transmigration, there is no loss in the 
integrity of the endothelial monolayer (Huang et al., 1988). However, in our 
imaging experiments, the endothelial retraction appeared to be followed by 
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permanent damage to the endothelial monolayer layer integrity. Similar 
findings were reported in a study of transmigration of human invasive bladder 
carcinoma cells across a monolayer of HUVECs. Real time confocal laser 
microscopy imaging demonstrated that post transmigration, there appeared to 
be permanent loss of endothelial monolayer integrity (Heyder et al., 2002). 
Hence, it can be inferred that unlike the physiological process of leucocyte 
transmigration, where the endothelial monolayer is not permanently damaged, 
the pathological process of tumour cell transmigration appears to cause 
irreversible damage of endothelial monolayer integrity. 
In conclusion, even though leucocyte adhesion and transmigration is thought to 
be a paradigm for adhesion and transendothelial migration during metastasis 
and to a considerable extent, there are similarities, there appear to be several 
differences. Adhesion and transendothelial migration of cancer cells is not as 
well understood as leucocyte adhesion and transendothelial migration. 
However, from the available evidence, the role of the key mediators appears to 
be not restricted to a particular step of the adhesion and transendothelial 
migration process and the changes produced due to cancer cell adhesion and 
transendothelial migration are more destructive and permanent.  
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6.3. Future Work 
 The results described in this thesis indicate that a potential functional 
role of HPA binding glycans in cancer cell-endothelial cell interactions 
may warrant further investigation. 
 Owing to the technical complexity of glycan analysis, one way forward 
may be to attempt to identify, isolate and characterise the putative 
endothelial cell receptor recognised by cancer cell GalNAc-glycans.  
 Though the role of HPA binding glycans during cancer cell-endothelial 
cell adhesion was investigated in the studies described in this thesis, the 
potential role of HPA binding glycans during transendothelial migration 
still has not been studied. This could be addressed using trans well 
migration assays and by mapping surface HPA binding glycans with 
fluorescent labels during various stages of adhesion and transendothelial 
migration. 
 Imaging the ashesion assays has revealed several interesting 
observations. However, these studies need to be extended to obtain 
more quantitative and qualitative data, particularly using high resolution 
imaging with SEM, by using flow assays in a three-dimensional model, 
in animal studies and real time imaging modalities 
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